Pasar al contenido principal

DESARROLLO DE NUEVOS MATERIALES INTELIGENTES Y SU APLICACION COMO SISTEMAS ANTIVIRALES, ANTIBIOFILM, ANTIENZIMATICOS Y ANTIMICROBIANOS PARA LA INDUSTRIA ALIMENTARIA.

PID2021-128141OB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 43
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Ficin-Cyclodextrin-Based Docking Nanoarchitectonics of Self-Propelled Nanomotors for Bacterial Biofilm Eradication

  • Ziemyte, Migle
  • Diez-Sánchez, Paula
  • Ferrer, María D.
  • Mira, Alex
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Murguía, Jose R.|||0000-0001-9364-4603
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Development of bioinspired nanomotors showing effective propulsion and cargo delivery capabilities has attracted much attention in the last few years due to their potential use in biomedical applications. However, implementation of this tech-nology in realistic settings is still a barely explored field. Herein, we report the design and application of a multifunctional gated Janus platinum-mesoporous silica nanomotor constituted of a propelling element (platinum nanodendrites) and a drug-loaded nano-container (mesoporous silica nanoparticle) capped with ficin enzyme modified with beta-cyclodextrins (beta-CD). The engineered nanomotor is designed to effectively disrupt bacterial biofilms via H2O2-induced self-propelled motion, ficin hydrolysis of the extracellular polymeric matrix (EPS) of the biofilm, and controlled pH-triggered cargo (vancomycin) delivery. The effective synergic antimicrobial activity of the nanomotor is demonstrated in the elimination of Staphylococcus aureus biofilms. The nanomotor achieves 82% of EPS biomass disruption and a 96% reduction in cell viability, which contrasts with a remarkably lower reduction in biofilm elimination when the components of the nanomotors are used separately at the same concentrations. Such a large reduction in biofilm biomass in S. aureus has never been achieved previously by any conventional therapy. The strategy proposed suggests that engineered nanomotors have great potential for the elimination of biofilms., The authors acknowledge financial support from Project CIPROM/2021/007 from the Generalitat Valenciana. This research was also supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund - A way of doing Europe. This study was also part of the Advanced Materials Program (MFA/2022/053) supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This research was also funded by Universitat Politecnica de Valencia and the FISABIO Foundation, NANO-DRILL Project (UGP-19-384), and NANODONT Project (UPV-FISABIO-2020-B14). The authors gratefully acknowledge the support of the European Research Council (ERC) via the Advanced Grant (101052997, EDISON). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council . Neither the European Union nor the granting authority can be held responsible for them. M.Z. thanks for her FPU Ph.D. scholarship by the Spanish government (FPU17/01302). A.E. is also grateful for her Ph.D. grant from the Generalitat Valenciana (ACIF/2018/110). P.D. thanks Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120). V.M-C. acknowledges financial support from Project CIDE-GENT/2020/031, funded by Generalitat Valenciana. Scheme 1, (top) and Figure 3a were created with BioRender.com.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment

  • Parés, Marta
  • Pallaruelo-Santamaría, Víctor
  • Fillat, Cristina
  • Martínez-Latorre, Javier|||0000-0001-5421-5371
  • Candela-Noguera, Vicente
  • Soriano-Teruel, Paula
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive and treatment-resistant malignancies, with limited efficacy to conventional treatments such as surgical resection or chemotherapy. This clinical scenario underscores the need for novel therapeutic strategies. The development of multifunctional platforms capable of targeting tumors through multiple mechanisms offers an innovative strategy to overcome this challenge. Lipid nanoparticles (LNPs) offer a versatile platform capable of efficiently delivering genetic material. Moreover, through surface functionalization it is feasible to improve LNP performance optimizing therapeutic outcomes in a single formulation. Here, we explored a dual functionalization strategy of the LNP for tumor targeting and tumor remodeling to improve treatment efficacy. LNPs were designed for delivering reporter DNA plasmid or mRNA into the PDAC cellular models Capan-2 and PANC-1. The DNA plasmid contains a pancreatic cancer-specific chimeric promoter for transcriptional specificity to PDAC cells. Besides, LNPs were functionalized with folate and an anti-CD47 antibody to both target the folate receptor in PDAC cells and block CD47-mediated immune evasion. Both pDNA and mRNA LNPs targeted PDAC cells in a dose-dependent manner, with mRNA-LNPs demonstrating more efficient transfection. Notably, LNPs functionalized with the anti-CD47 antibody increased phagocytosis in vitro, and promoted an inflammatory phenotype of M1-like macrophages in mouse Capan-2 xenografts. This combinatorial design of the formulated LNP represents an innovative therapeutic strategy and opens future perspectives in the search for effective treatments for PDAC. Keywords: Lipid nanoparticles; Immunotherapy; ACD47; Folate; Macrophages; Pancreatic cancer, This research was supported by European Union s Horizon 2020 research and innovation programme under grant agreement No 899708 (ULISES). The work has also received funding from projects PID2020- 119692RB-C22, PID2023-146637OB-C22, PID2021-128141OBC22, PID2021-126304OB-C41 and PID2024-155683OB-C41 funded by MCIN-Ministerio de Ciencia e Innovacion ¿ and by the European Regional Development Fund A way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012) and (RD21/0017/0012) Instituto de Salud Carlos III, the Generalitat de Catalunya (SGR21/01169). The research leading to these results has also received funding from la Caixa Foundation under agreement LCF/PR/ SP23/52950009. The Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. J.M-L. is grateful to the Spanish MECD for his FPU grant (FPU19/06219). PM.S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). We also acknowledge the support of CERCA Programme/Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Development of a novel near-infrared fluorescent probe based on nile blue for the detection of leucine aminopeptidase as a cancer biomarker.

  • Domínguez-Rodríguez, Marcia|||0000-0002-0635-0699
  • Azorín-Soriano, David
  • García-Fleitas, Jessie
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Soler-Beatty, Jennifer
  • Blandez, Juan F.
[EN] We report herein the design and synthesis of a near-infrared fluorescent probe (NB¿SO3-Leu) derived from the Nile Blue (NB) fluorophore scaffold, modified with sulfonic groups to improve solubility and biocompatibility. The mechanism of action of the NB-SO3-Leu probe was successfully validated in the presence of leucine aminopeptidase (LAP), a widely known cancer biomarker. The fluorescence signal of NB-SO3-Leu, which was initially low, increased 4-fold after incubation with the LAP enzyme after 15 min. In addition, the NB-SO3-Leu probe was validated in vitro in 4T1 (mouse mammary carcinoma cells), HeLa (human cervical cancer cells), and SK-Mel-103 (human melanoma cells) with high endogenous LAP levels. This work aims to advance in the development of a new generation of reliable and sensitive cancer detection methods., This research was supported by project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/ 501100011033/and by European Regional Development Fund - A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). Thank the financial support from the FEDER found of European Union (IDIFEDER/2021/044). This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. ¿ J. F. B. thanks to his postdoctoral fellowship APOSTD from Generalitat Valenciana (CIAPOS/2021/198).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In-depth study of factors affecting the formation of MCM-41-type mesoporous silica nanoparticles

  • Candela-Noguera, Vicente
  • Alfonso-Navarro, María
  • Amorós, Pedro
  • Aznar, Elena|||0000-0003-0361-3876
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Mesoporous silica nanoparticles (MSN), especially MCM-41 type, have been broadly studied and used in different applications such as catalysis, nanomedicine and environmental science. One of the most advantageous properties of these materials is their easy and tunable synthesis. Nevertheless, in spite of the efforts made by researchers in the last decades, there is still no complete understanding of the mechanism and factors affecting the formation of MCM-41 type MSN, and some parameters are disregarded in the reported synthesis protocols. Considering that the fine-tuning of the parameters affecting nanoparticle synthesis is the basis for obtaining welldefined nanodevices with advanced complex functionalities, an in-depth study of the factors affecting the formation of MCM-41 type MSN is carried out in this work. We analyzed the first stages of MSN formation, namely the silica-surfactant templating and nanoparticle nucleation and growth, and found that hydrolysis and condensation rates play a central role in nanoparticle formation. Furthermore, we found that some disregarded parameters in the MCM-41 type synthesis, such as the stirring strength or the surfactant addition rate, modulate nucleation and growth, influencing the hydrolysis and condensation rates. Finally, we studied the aging and the evolution of the MSN by analyzing the consolidation of the silica framework over time. Therefore, we further elucidate some points about the mechanism and factors affecting the formation of mesoporous silica, which brings us closer to obtaining reproducible, homogeneous and tailored-made MCM-41 type MSN., Vicente Candela-Noguera thanks the Spanish Government for his fellowship (FPU15/02753) . This research was supported by projects PID2021-126304OB-C41, PID2021-126304OB-C43 and PID2021- 128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This study also forms part of the Advanced Materials programme (MFA/2022/049 and MFA/2022/053) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . The authors also thank the Electron Microscopy Service at UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.

  • López-Palacios, Alba|||0000-0002-4397-277X
  • Caballos-Gómez, María Isabel
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Aranda-Sobrino, María Nieves
  • Calbuig, Eva
  • Gómez-Ruiz, María Dolores
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Climent Terol, Estela
[EN] We describe herein a sensor containing nanoporous anodic alumina (NAA) as sensing platform to identify SARSCOV-2 RNA using a gating mechanism. The system is based on NAA that contains a fluorescent dye (Rhodamine B; RhB) and is capped with an oligonucleotide sequence that hybridize specifically a region of SARS-CoV-2 genome. In the presence of RNA from SARS-COV-2 virus, the oligonucleotide of the surface is displaced, uncapping the pores, and producing a delivery of RhB. The detection of the virus is achieved measuring the fluorescence of the fluorophore. The nanosensor demonstrates to be highly sensitive and selective in aqueous buffers and in biological media, having a limit of detection (LOD) of 50 ± 30 copies mL-1 of SARS-CoV-2 RNA extracted from patients. Moreover, preliminary results using 18 real nasopharyngeal swab samples indicate the potential of the system to differentiate between infected and non-infected patients. Compared to the conventional RT-PCR method, in our system there is no need for sample pretreatment or RNA isolation, providing diagnostic outcomes within 60 mins while maintaining a high level of reliability, This study was sponsored by the Spanish Government (projects PID2021-126304OB-C41 (DOROTHY), PID2021-128141OB-C22 (ANTIVIBEM), and PID2021-122875OB-100 (MCUI/AEI/ FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/ 2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Polit`ecnica de Val`encia− Instituto de Investigacion ¿ Sanitaria La Fe (IISLaFe) (SARS-COV-2-SEEKER and VISION-COV projects). This research project has received funding from the European Union s HORIZON-CL4- 2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor th e granting authority can be held responsible for them. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). Also, the project has received funding from the European Union s HORIZON-CL4-2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. A.L.P. thanks the Ministerio de Universidades for his predoctoral grant (FPU20/05297). E. C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086). Scheme 1 was done with BioRender.com. The Medicaments Research Ethics Committee, CEIm of University and Polytechnic La Fe Hospital of Valencia (2021-012-1) approved the use of samples from human patients.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Development and validation of novel senolytic strategies for targeting and eliminating senescent cells

  • Escriche Navarro, Blanca
[ES] Esta tesis doctoral titulada "Desarrollo y validación de nuevas estrategias senolíticas para la selección y eliminación de células senescentes" se centra en el diseño, síntesis y validación de nanodispositivos y profármacos para eliminar células senescentes, con el objetivo de tratar enfermedades relacionadas con el envejecimiento y el cáncer. En el primer capítulo experimental, presentamos un nanodispositivo para eliminar selectivamente células senescentes explotando la actividad enzimática específica del secretoma senescente. Los resultados mostraron que tras la inducción de senescencia en fibroblastos WI-38 proliferantes con radiación ionizante, las células secretan altos niveles de metaloproteinasa de matriz 3 (MMP-3). Basándose en esto, se cargaron MSNs con navitoclax y se recubrieron con un péptido específico de MMP-3 ( "puerta molecular"), obteniendo NPs(Nav)@MMP-3. Los estudios celulares demostraron una liberación preferencial de la carga en células senescentes en comparación con células proliferantes. Además, el tratamiento de células senescentes con NPs(Nav)@MMP-3 indujo una disminución de la viabilidad celular similar a la del navitoclax, mientras que se observó un efecto protector sobre las células proliferantes. Partiendo de estos resultados en el segundo capítulo experimental describimos una nanopartícula para terapia senolítica mediada por células inmunitarias. Para ello, las nanopartículas recubiertas con el péptido específico de MMP-3 se decoraron con la quimioquina CXCL12 (NPs@CXCL12), potenciando el reclutamiento de células inmunitarias al microambiente senescente. Se verificó la liberación progresiva y específica de la proteína CXCL12 en presencia de MMP-3 mediante ensayos de liberación controlada. Posteriormente, se confirmó la capacidad de las nanopartículas para atraer células T Jurkat a un microambiente senescente mediante ensayos de migración. Los resultados revelaron que las NPs@CXCL12 ejercían un efecto quimiotáctico más significativo que la CXCL12 libre. Además, también se evaluó la capacidad de las células asesinas naturales primarias humanas para eliminar WI-38 senescentes, y se monitorizaron sus trayectorias de migración en respuesta a NPs@CXCL12 o CXCL12 libre utilizando un dispositivo de microfuídica. En el capítulo experimental tres, nos centramos en el diseño de un nanodispositivo dirigido al surfaceoma senescente. En concreto, demostramos que la inducción de la senescencia con palbociclib en células de melanoma humano desarrollaba un fenotipo senescente con sobreexpresión de dipeptidil peptidasa-4 (DPP4).Aquí, se cargaron MSNs con navitoclax, se cubrieron con polietilenglicol que contiene disulfuro ("puerta molecular" sensible a redox) y se funcionalizaron con un anticuerpo contra DPP4. La eficacia de las NPs(Nav)@DPP4-PE en la detección y eliminación de células senescentes se validó in vitro e in vivo utilizando un modelo murino de melanoma senescente inducido por palbociclib. El tratamiento redujo significativamente el crecimiento tumoral y eliminó preferentemente las células senescentes. En el cuarto capítulo experimental, investigamos el potencial de la terapia fotodinámica para la detección y eliminación de células senescentes. Para ello, se sintetizó un fotosensibilizador (compuesto 1) basado en boro-dipirrometeno (BODIPY) activado con ß-galactosidasa asociada a senescencia (SA-ß-gal). El compuesto 1 permanece inactivo hasta que la hidrólisis de la galactosa por la enzima SA-ß-gal restaura la emisión de fluorescencia y la generación de oxígeno singlete. La restauración de la fluorescencia, la capacidad de producir especies reactivas de oxígeno y de matar células senescentes en presencia de luz en el compuesto 1 se demostró en modelos de senescencia inducida por terapia in vitro e in vivo. Además, los estudios revelaron que el compuesto 1 desencadena un potente efecto senolítico tras la irradiación de tumores senescentes en modelos de ratón., [CA] Esta tesi doctoral titulada "Desenvolupament i validació de noves estratègies senolítiques per a la selecció i eliminació de cèl·lules senescents" se centra en el disseny, síntesi i validació de nanodispositius i profàrmacs per a eliminar cèl·lules senescents, amb l'objectiu de tractar malalties relacionades amb l'envelliment i el càncer. En el primer capítol experimental, presentem un nanodispositiu per a eliminar selectivament cèl·lules senescents explotantl'activitat enzimàtica específica del secretoma senescent. Els resultats van mostrar que després de la inducció de senescència en fibroblasts WI-38 proliferants amb radiació ionitzant, les cèl·lules secreten alts nivells de metaloproteinasa de matriu 3 (MMP-3). Basant-se en això, es van carregar MSNs amb navitoclax i es van recobrir amb un pèptid específic de MMP-3 ("porta molecular"), obtenint NPs(Nav)@MMP-3. Els estudis cel·lulars van demostrar un alliberament preferencial de la càrrega en cèl·lules senescents en comparació amb cèl·lules proliferants. A més, el tractament de cèl·lules senescents amb NPs(Nav)@MMP-3 va induir una disminució de la viabilitat cel·lular similar a la del navitoclax, mentres que es va observar un efecte protector sobre les cèl·lules proliferants. Partint déstos resultats en el segon capítol experimental descrivim una nanopartícula per teràpia senolítica mediada per cèl·lules immunitàries. Per a això, les nanopartícules recobertes amb el pèptid específic de MMP-3 es van decorar amb la quimioquina CXCL12 (NPs@CXCL12), potenciant el reclutament de cèl·lules immunitàries al microambient senescent. Ees va verificar l'alliberament progressiu i específic de la proteïna CXCL12 de la bastida en presència de MMP-3 mitjançant assajos d'alliberament controlat. Posteriorment, es va confirmar la capacitat de les nanopartícules per a atraure cèl·lules T Jurkat a un microambient senescent mitjançant assajos de migració. Els resultats van revelar que les NPs@CXCL12 exercien un efecte quimiotàctic més significatiu que la CXCL12. A més, també es va avaluar la capacitat de les cèl·lules assassines naturals primàries humanes per a eliminar WI-38 senescents, i es van monitorar les seues trajectòries de migració en resposta a NPs@CXCL12 o CXCL12 utilitzant un dispositiu de microfuidica. En el capítol experimental tres, ens centrem en el disseny d'un nanodispositiu dirigit al surfaceoma senescent. En concret, vam demostrar que la inducció de la senescència amb palbociclib en cèl·lules de melanoma humà presentava un fenotip senescent amb sobreexpresión de dipeptidil peptidasa-4 (DPP4). Basant-se en esta troballa, es van carregar MSNs amb navitoclax, es van cobrir amb polietilenglicol que conté disulfur, ("porta molecular" sensible a redox) i es van funcionalitzar amb un anticòs contra DPP4. L'eficàcia de les NPs(Nav)@DPP4-PE en la detecció i eliminació de cèl·lules senescents es va validar in vitro i in vivo utilitzant un model murin de melanoma senescent induït per palbociclib.El tractament va reduir significativament el creixement tumoral i va eliminar preferentment les cèl·lules senescents, com van indicar els biomarcadores de senescència analitzats. En el quart capítol experimental, investiguem el potencial de la teràpia fotodinámica per a la detecció i eliminació de cèl·lules senescents. Per a això, es va sintetitzar un fotosensibilizador (compost 1) basat en bor-dipirrometeno activat amb ß-galactosidasa associada a senescència (SA-ß-gal). El 1 roman inactiu fins que la hidròlisi de la galactosa per SA-ß-gal restaura l'emissió de fluorescència i la generació d'oxigen singlete. La restauració de la fluorescència, la capacitat de produir espècies reactives d'oxigen i de matar cèl·lules senescents en presència de llum en el 1 es va demostrar en models de senescència induïda per teràpia in vitro i in vivo. A més, els estudis van revelar que el 1 desencadena un potent efecte senolítico després de la irradiació de tumors senescents en models de ratolí., [EN] This PhD thesis entitled "Development and validation of novel senolytic strategies for targeting and eliminating senescent cells" focuses on the design, synthesis, and validation of nanodevices and prodrugs to eliminate senescent cells, to treat diseases related to aging and cancer. In the first experimental chapter, we present a nanodevice to selectively remove senescent cells by exploiting the specific enzymatic activity of the senescent secretome. The results showed that after the induction of senescence in proliferating WI-38 fibroblasts with ionizing radiation, the cells secrete high levels of matrix metalloproteinase-3 (MMP-3). Based on this, MSNs were loaded with navitoclax and coated with a specific peptide; a substrate of MMP-3 (gatekeeper), yielding NPs(Nav)@MMP-3. Cellular studies demonstrated preferential cargo release in senescent cells compared to proliferating cells. Furthermore, treatment of senescent cells with NPs(Nav)@MMP-3 induced a decrease in cell viability similar to that of free navitoclax, while a protective effect on proliferating cells was observed. Building on these results, in the second experimental chapter, we describe a nanoparticle for immune cell-mediated senolytic therapy. To this end, MSNs coated with the specific peptide MMP-3 were decorated with the chemokine CXCL12 (NPs@CXCL12), enhancing immune cells' recruitment to the senescent microenvironment. First, the progressive and specific release of CXCL12 protein from the scaffold in the presence of MMP-3 was verified by controlled release assays. Subsequently, the ability of the nanoparticles to attract Jurkat T cells to a senescent microenvironment was confirmed by migration assays. The results revealed that NPs@CXCL12 exerted a more significant chemotactic effect than free CXCL12. In addition, the ability of human primary natural killer cells to clear senescent WI-38 was also evaluated, and their migration trajectories were monitored in response to NPs@CXCL12 or free CXCL12 using a microfluidic device. In experimental chapter three, we focused on the design of a nanodevice targeting senescent surfaceome. Specifically, the research proved that the induction of senescence with palbociclib in human melanoma cells developed a senescent phenotype characterized by the up-regulated expression of dipeptidyl peptidase 4 (DPP4). Based on this finding, MSNs were loaded with navitoclax, capped with disulfide-containing polyethylene glycol (redox-sensitive gatekeeper) and finally functionalized with an antibody that recognized the DPP4 protein. The efficacy of NPs(Nav)@DPP4-PE in detecting and eliminating senescent cells was validated in vitro and in vivo using a mouse model of palbociclib-induced senescent melanoma. Furthermore, treatment of mice with the DPP4-targeted nanoparticle significantly reduced tumor growth, and preferentially removed senescent cells, as indicated by the senescence biomarkers analyzed. In the fourth experimental chapter, we investigated the potential of photodynamic therapy for the detection and eradication of senescent cells. For this purpose, a boron dipyrromethene-based photosensitizer (BODIPY) activated with senescent-associated ß-galactosidase (SA-ß-gal) (compound 1) was synthesized. Compound 1 contains a galactose moiety bound to a BODIPY, so it remains inactive until galactose hydrolysis by the SA-ß-gal enzyme restores fluorescence emission and singlet oxygen generation. The restoration of fluorescence, the ability to produce reactive oxygen species, and to kill senescent cells in the presence of light in compound 1 was demonstrated in models of therapy-induced senescence in vitro and in vivo. Furthermore, studies in palbociclib-induced senescent melanoma mouse models reveal that the galactose-conjugated photosensitizer triggers a potent senolytic effect upon irradiation of senescent tumors., This research was supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/ AEI /10.13039/501100011033/ and by EuropeanRegional Development Fund - A way of doing Europe. This study was also supported byGeneralitat Valenciana (CIPROM/2021/007). This research was supported by CIBER(CB06/01/2012), Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovación. Thiswork was also supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project “IFI19/00026”, co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her “Margarita Salas” postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Heavy-atom-free BODIPY-based photodynamic therapy agents activated at long wavelengths

  • Soler-Beatty, Jennifer
  • Avellanal-Zaballa, Edurne
  • Durán-Sampedro, Gonzalo
  • Agarrabeitia, Antonia R.
  • Bañuelos, Jorge
  • Ortiz, María J.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Photodynamic therapy (PDT) is an emerging clinical tool that uses light as an agent unleashing cytotoxic activity for treating cancer and other diseases, including those showing drug resistance. One of the main areas of research to fully implement PDT as a real alternative to chemo or radiotherapy is the development of improved photosensitizers (PSs). This work aims to contribute to the design of novel PSs able to generate reactive oxygen species (ROS) upon activation with light within the biological window (deep red or near-infrared region) while being non-toxic under dark conditions (heavy-atom-free). For this, we have chosen BODIPY-based covalent dimers directly linked through their 3-position as model structures. This molecular scaffold has been previously tested as a fluorescent probe to stain cells, but not as a PS for ROS generation under red illumination. Using readily available synthetic protocols, we have changed the steric hindrance around the linkage and added functional groups suited to enhance targetable biorecognition and solubility in physiological media. The spectroscopic characterization confirms that these dimers are photoactivated in a spectral window approaching 700 nm and display noticeable fluorescence signals beyond this wavelength, together with a notable generation of singlet oxygen. Encouraged by these photophysical signatures, we conducted in vitro trials in cancer cells. These assays ratify the ability of most of the herein reported dimers to sensitize ROS and induce cell death upon long-wavelength illumination., The authors acknowledge grants PID2020-114755GB-C32 and -C33, and PID2021-128141OB-C22 funded by the Spanish MCIN/AEI/10.13039/501100011033, and grant IT1639-22 funded by the Basque Government.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Gated Nanosensor for Sulphate-Reducing Bacteria Detection

  • López-Palacios, Alba|||0000-0002-4397-277X
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Moreno Trigos, Mª Yolanda|||0000-0003-3688-5157
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Ponz-Carcelén, Román
  • Pedro-Monzonís, María
[EN] Desulfovibrio vulgaris is an anaerobic microorganism belonging to the group of sulphate-reducing bacteria (SRB). SRB form biofilms on metal surfaces in water supply networks, producing a microbiologically influenced corrosion (MIC). This process produces the deterioration of metal surfaces, leading to high economic costs and different environmental safety and health problems related to its chemical treatment. For that reason, rapid and accurate detection methods of SRB are needed. In this work, a new detection system for Desulfovibrio has been developed using gated nanoporous materials. The probe is based on hybrid nanoporous alumina films encapsulating a fluorescent molecule (rhodamine B), whose release is controlled by an oligonucleotide gate. Upon exposure to Desulfovibrio's genomic material, a movement of the oligonucleotide gatekeeper happens, resulting in the selective delivery of the entrapped rhodamine B. The developed material shows high selectivity and sensitivity for detecting Desulfovibrio DNA in aqueous buffer and biological media. The implementation of this technology for the detection of Desulfovibrio as a tool for monitoring water supply networks is innovative and allows real-time in situ monitoring, making it possible to detect the growth of Desulfovibrio inside of pipes at an early stage and perform timely interventions to reverse it., This research was supported by project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-A way of doing Europe. The work was also supported by Generalitat Valenciana (CIPROM/2021/007), Agencia Valenciana de la Innovacio (INNEST/2021/169, Universitat Politecnica de Valencia; INNEST/2021/174, Global Omnium) and is susceptible to be co-founded by European Union. This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. A.L. thanks to the Ministerio de Universidades for her predoctoral grant (FPU20/05297). A.M.-A. thanks to the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

New Strategies to Enhance the Quality and Safety of Liquid Foods Based on the Use of Natural Antimicrobial Compounds

  • Gómez-Llorente, Héctor|||0000-0001-5968-6041
[ES] Los componentes de los aceites esenciales (CAEs) han demostrado ser eficaces contra una amplia variedad de microorganismos. Sin embargo, su aplicación plantea desafíos debido a su baja solubilidad y alteración de las propiedades organolépticas en los alimentos. Por tanto, la búsqueda de nuevas formas de dosificación es fundamental para promover su uso en la industria alimentaria. La presente tesis doctoral está centrada en el desarrollo y aplicación de sistemas antibacterianos y antivirales basados en la inmovilización covalente de CAEs para mejorar la calidad y seguridad de alimentos líquidos. El primer capítulo evaluó el efecto de la adición de componentes naturalmente presentes en los alimentos (proteínas, lípidos, carbohidratos, ácidos orgánicos y etanol) sobre la actividad antimicrobiana de diferentes CAEs (carvacrol, eugenol, geraniol, timol y vainillina) en su forma libre. Además, se evaluó la influencia de los componentes alimentarios sobre la vainillina inmovilizada. Los resultados mostraron que la albúmina sérica bovina (BSA), el aceite de girasol y algunos carbohidratos fueron los componentes que más inhibieron la actividad antimicrobiana de los CAEs libres, con algunas excepciones. En los medios que contienen BSA, no se inhibió la actividad antimicrobiana del geraniol. Lo mismo ocurrió con eugenol en aceite de girasol, o con carvacrol, eugenol, geraniol y timol en presencia de D-lactosa. La vainillina inmovilizada confirmó el efecto inhibidor de las proteínas, lípidos y carbohidratos sobre la actividad antimicrobiana, pero el ácido cítrico y el etanol mejoraron la actividad antimicrobiana. Estos resultados demuestran la importancia de considerar la composición de la matriz alimentaria al seleccionar un compuesto antimicrobiano. El segundo capítulo evaluó la aplicación de CAEs frente al crecimiento y producción de guaiacol por un microorganismo alterante y termorresistente como Alyciclobacillus acidoterrestris en zumo de naranja. Para ello, se utilizaron CAEs inmovilizados con dos enfoques diferentes: como aditivos y como coadyuvantes tecnológicos. La presencia de CAEs provocó una reducción microbiana y una inhibición de la producción de guayacol, que fue mantenida tras la inmovilización. Este hecho es de gran interés, ya que la inmovilización evita el problema de alteración organoléptica del producto, derivado de la aplicación de estos antimicrobianos en forma libre. En el tercer capítulo se estudió la actividad antiviral de los CAEs, tanto en forma libre como inmovilizada, frente al virus Tulane en agua. La aplicación de CAEs en forma libre logró una reducción de la infectividad de sólo 1 log10, mientras que concentraciones equivalentes de antimicrobiano inmovilizado redujeron la infectividad a más de 4,5 log10. Por otro lado, el mecanismo antiviral se basó en la modificación o alteración de cápside viral. Además, se determinó que los CAEs inmovilizados no son citotóxicos en concentraciones antivirales efectivas. A pesar de la eficacia observada tras la inmovilización de los CAEs, su aplicación práctica en la industria alimentaria presenta varios desafíos, siendo uno de ellos la aceptación de esta tecnología por parte de los consumidores. El último capítulo estudió la percepción de los consumidores sobre el uso de la nanotecnología en el procesamiento de alimentos. La valoración de los distintos alimentos en los que se había aplicado nanotecnología en su procesamiento o envasado fue en general positiva. De todos los productos, aquellos en los que la nanotecnología no formaba parte de los alimentos recibieron la mejor valoración. Teniendo en cuenta este resultado, los CAEs inmovilizados aplicados como coadyuvantes tecnológicos serían los más valorados y, por tanto, podrían ser una excelente alternativa a los tratamientos de conservación convencionales, para controlar tanto virus como bacterias durante la producción y el almacenamiento de alimentos., [CA] Els components dels olis essencials (COEs) han demostrat ser eficaços en fornt d'una àmplia varietat de microorganismes. Tot i això, la seua aplicació planteja desafiaments a causa de la seua baixa solubilitat i alteració de les propietats organolèptiques en els aliments. Per tant, la recerca de noves formes de dosificació és fonamental per promoure'n l'ús a la indústria alimentària. Aquesta tesi doctoral està centrada en el desenvolupament i l'aplicació de sistemes antibacterians i antivirals basats en la immobilització covalent de COEs per a millorar la qualitat i la seguretat d'aliments líquids. El primer capítol va avaluar l'efecte de l'addició de components naturalment presents als aliments (proteïnes, lípids, carbohidrats, àcids orgànics i etanol) sobre l'activitat antimicrobiana de diferents COEs (carvacrol, eugenol, geraniol, timol i vainillina) en la seua forma lliure. En aquesta primera part també es va avaluar la influencia dels components alimentaris sobre la vainillina immobilitzada. Els resultats van mostrar que l'albúmina sèrica bovina (BSA), l'oli de gira-sol i alguns carbohidrats van ser els components que van inhibir més l'activitat antimicrobiana dels COEs lliures, amb algunes excepcions. Als mitjans que contenen BSA no es va inhibir l'activitat antimicrobiana del geraniol. El mateix va passar amb eugenol en oli de gira-sol, o amb carvacrol, eugenol, geraniol i timol en presencia de D-lactosa. La vainillina immobilitzada va confirmar l'efecte inhibidor de les proteïnes, els lípids i els carbohidrats sobre l'activitat antimicrobiana, però l'àcid cítric i l'etanol van millorar l'activitat antimicrobiana. Aquests resultats demostren la importància de considerar la composició de la matriu alimentària quan s'ha de seleccionar un compost antimicrobià per a una aplicació concreta. El segon capítol va avaluar l'aplicació de COEs en front del creixement i la producció de guaiacol per un microorganisme alterant i termorresistent com Alyciclobacillus acidoterrestris en suc de taronja. Per això, es van utilitzar COEs immobilitzats amb dos enfocaments diferents: com a additius i com a coadjuvants. La presència de COEs provoca una reducció microbiana i una inhibició de la producció de guaiacol, així com manté la seua eficàcia després de la immobilització. Aquest fet és de gran interès, ja que la immobilització evita el problema d'alteració organolèptica del producte, derivat de l'aplicació d'aquests antimicrobians en forma lliure. Al tercer capítol es va estudiar l'activitat antiviral dels COEs, tant en forma lliure com immobilitzada, davant del virus Tulane en aigua. L'aplicació de COEs en forma lliure va aconseguir una reducció de la infectivitat de només 1 log10, mentre que concentracions equivalents d'antimicrobià immobilitzat van reduir la infectivitat a més de 4,5 log10. D'altra banda, es va comprobar que el mecanisme antiviral es va basar en la modificació o alteració de la càpside viral. A més, es va determinar que els COEs immobilitzats no són citotòxics en concentracions antivirals efectives. Tot i l'eficàcia observada després de la immobilització dels COEs, la seua aplicació pràctica a la indústria alimentària presenta diversos desafiaments, un dels quals és l'acceptació d'questa tecnologia per part dels consumidors. El darrer capítol va estudiar la percepció dels consumidors sobre l'ús de la nanotecnologia en el processament d'aliments. La valoració dels diferents aliments en que s'havia aplicat nanotecnologia al seu processament o envasat va ser en general positiva. De tots els productes, aquells en que la nanotecnologia no formava part dels aliments van rebre la millor valoració. Tenint en compte aquest resultat, els COEs immobilitzats aplicats com a coadjuvants de processament serien els més valorats i, per tant, podrien ser una alternativa excel·lent als tractaments de conservació convencionals, per controlar tant virus com bacteris durant la producció i l'emmagatzematge d'aliments., [EN] Essential oil components (EOCs) have proven to be effective against a wide variety of microorganisms. However, the direct application of these compounds poses challenges due to their low solubility and alteration of the organoleptic properties of foods. Therefore, the search for new dosage forms of these promising antimicrobials is essential to promote their use in the food industry. The present doctoral thesis is focused on the development and application of antibacterial and antiviral systems based on the covalent immobilization of EOCs to improve the quality and safety of liquid foods. The first chapter evaluated the effect of the addition of components naturally present in food (proteins, lipids, carbohydrates, organic acids and ethanol) on the antimicrobial activity of certain EOCs (carvacrol, eugenol, geraniol, thymol and vanillin) in their free form. In this first part, the influence of these food components on the antimicrobial activity of vanillin immobilized on silicon oxide particles was also evaluated. The results showed that bovine serum albumin (BSA), sunflower oil and some carbohydrates were the food components that most inhibited the antimicrobial activity of the free EOCs, with some exceptions. In media containing BSA the antimicrobial activity of geraniol was not inhibited. The same occurred with eugenol in media containing sunflower oil, or with carvacrol, eugenol, geraniol and thymol in media with D-lactose. Immobilized vanillin confirmed the inhibitory effect of the proteins, lipids and carbohydrates on the antimicrobial activity, but citric acid and ethanol enhanced the antimicrobial activity. These results demonstrate the importance of considering the composition of the food matrix when selecting an antimicrobial compound. The second chapter evaluated the application of EOCs against the growth and production of guaiacol by a spoilage and heat-resistant microorganism such as Alyciclobacillus acidoterrestris in orange juice. For this purpose, EOCs immobilized on silicon oxide particles were used with two different approaches: as additives and as processing aids. The presence of EOCs causes a microbial reduction and an inhibition of guaiacol production, maintaining their effectiveness after immobilization. This fact is of great interest, since immobilization avoids the problem of organoleptic alteration of the product, derived from the application of these antimicrobials in free form. In the third chapter, the antiviral activity of EOCs, both in free and immobilized form, against Tulane virus in water was studied. The application of EOCs in free form achieved a reduction in infectivity of only 1 log10, equivalent concentrations of immobilized antimicrobial reduced infectivity to more than 4.5 log10. On the other hand, it has been demonstrated that the antiviral mechanism is based on the ability of immobilized antimicrobials to modify or disrupt the viral capsid. Furthermore, it was determined that immobilized EOCs are not cytotoxic at effective antiviral concentrations. Despite the efficacy observed after immobilization of EOCs against bacteria and viruses, their practical application in the food industry presents several challenges, one of them is the acceptance of this technology by consumers. Thus, the last chapter studied the perception of consumers regarding the use of nanotechnology in food processing. The evaluation of the different foods in which nanotechnology had been applied in their processing or packaging was generally positive, and most consumers would buy them. Of all the products, those in which nanotechnology was not part of the food received the best evaluation. Considering this result, immobilized EOCs applied as processing aids would be the most highly valued, and therefore could be an excellent alternative to conventional preservation treatments, to control both viruses and bacteria during food production and storage., This research forms part of project PID2021-128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. H.G.LL. acknowledges the Universitat Politécnica de València for his predoctoral fellowship. The authors acknowledge native English translator Helen Warburton for editing the text. The authors gratefully acknowledge the financial support from the project PID2021-128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work is also granted by the project TED2021- 132035B-I00, funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”. CG-B thanks the financial support received from the Spanish State Agency of Research (PID2022-136963OBI00/AEI/10.13039/501100011033), the Xunta de Galicia [ED431C 2021/29 and Centro singular de investigación de Galicia accreditation 2019-2022 (ED431G 2019/03)], and the European Regional Development Fund (ERDF). H.G.LL. acknowledges the Universitat Politècnica de València for his predoctoral fellowship. The authors gratefully acknowledge the financial support from the project PID2021- 128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work is also granted by the project TED2021-132035B-I00, funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”. H.G.LL. acknowledges the Universitat Politècnica de València for his predoctoral fellowship.The authors gratefully acknowledge the financial support for the experiment reported herein from the Spanish Government (RTI2018-101599-B-C21-AR). Héctor Gómez Llorente wishes to thank the Universitat Politècnica de València for the FPI Grant.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

LC biosensors (Bio-LC): new resonant sensors for direct detection of airborne viruses

  • Noguera Murray, Patricia Silvestre|||0000-0001-7155-0710
  • Pastor Navarro, Nuria
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Medaglia, Serena|||0000-0003-3537-9842
  • Alcañiz Fillol, Miguel|||0000-0002-4579-9210
  • Masot Peris, Rafael|||0000-0002-1114-649X
  • Giménez-Romero, David
[EN] Viruses suspended in the air are key in the transmission of infectious diseases. We present a label-free selective system capable of detecting in situ airborne viruses in ambient air, employing resonant LC (Inductor-Capacitator) circuits. As proof of principle, M13 bacteriophages were nebulized and monitored with this sensor. The selective recognition of viruses by the copper immune-functionalized inductor of an LC circuit resulted in shifts of its resonant frequency proportional to the virus ambient concentration. The selectivity of this resonator is due to the employed bioreceptor. So, the lowest ambient concentration of airborne M13 bacteriophage that can be selectively detected is 3 x 105 pfu L- 1. This biosensing approach opens appealing perspectives for controlling the transmission of infectious diseases., The authors thank E.M.N. from IVIA for providing the E. coli strain culture and H.M.R. from ETSIAM-UPV for the use of the climate chamber. Additionally, gratitude is extended to the Electron Microscopy Service at UPV for their support. This research received support from projects PID2021-126304OBC44 and PID2021-128141OB-C22, funded by MCIN/AEI (Ref:/10.13039/501100011033/), project PROMETEO CIPROM/2021/007, funded by Generalitat Valenciana, and the European Regional Development Fund-A way of doing Europe. Additionally, it was supported by project PAID-PD-22, funded by Universitat Politecnica de Valencia (UPV). A.B. expresses gratitude for her BG20/00020 contract from MCIN.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines

  • Esteve-Sánchez, Yoel|||0000-0002-6845-1110
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Eva Calbuig
  • Gomez, Maria Dolores
  • Climent Terol, Estela
[EN] Methods to detect naturally infected individuals, especially during or after a pandemic, are valuable in populations with a high rate of vaccination. Having in mind that after the COVID-19 pandemic people has been vaccinated against the virus by Spike protein (S)-based vaccines, we present in this paper a novel nanosensor based on gated nanoporous anodic alumina (NAA) material to detect naturally infected individuals in populations with high rates of vaccination. The nanosensor developed is based on a protein-capped nanomaterial for the identification of IgG antibodies that can detect nucleocapsid protein (N) of SARS-CoV-2. The NAA material has been loaded with an indicator (Rhodamine B (RhB)) and the pores of the material have been blocked with SARS-CoV-2 nucleocapsid protein (N) attached to a specific aptamer. In presence of antibodies against this antigen, the pores are uncapped, triggering the dye release and a fluorescent signal as a result. The biosensor has been tested in vitro and simulated serum for IgG detection, proving a detection limit of 1 mu g/mL. Moreover, specificity assays with N proteins from other coronaviruses have proved the robustness and efficacy of this nanosensor. Finally, the system has been tested on samples from patients that contained SARS-CoV-2 antibodies, demonstrating its potential for the discrimination of individuals that have been vaccinated or infected by SARS-CoV-2 virus., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2021-122875OB-100 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This work was also funded by the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007) , Santander and CRUE Supera COVID-19 Fund (DIACOVID project) , the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects) . R.M thanks to the European Union's Horizon EUROPE Research and Innovation Program (grant agreement No 101093042) . Y.E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Politecnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.r E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Polite`cnic ` cnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Overcoming Antifungal Resistance: A Histatin 5-Gated Nanodevice for On-Demand Surfactant Delivery against Infections

  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Sanz-Álvarez, Víctor|||0009-0004-7967-6552
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • de Boer, Leonie
  • Zaat, Sebastian A. J.
  • Diez-Sánchez, Paula
[EN] The escalating incidence of fungal infections, coupled with the emergence of antifungal resistance, represents a formidable global public health challenge. is a common opportunistic fungus that causes life-threatening, widespread candidiasis, especially in immunocompromised patients. Conventional antifungals, including azoles, echinocandins, and polyenes, have some drawbacks, such as host toxicity and the rapid appearance of resistant fungal strains. To overcome these limitations, we engineered a stimuli-responsive gated antimicrobial nanoparticle using mesoporous silica nanoparticles, functionalized with the antimicrobial peptide histatin 5 (Hst5) and loaded with the surfactant (3-(methyl)-1-tetradecylimidazolium) [C14MIM]+. The nanoparticles exhibit potent antimicrobial activity against , with minimum inhibitory concentration values comparable to current clinical antifungals. Crucially, the nanodevice exhibits a dual mechanism of action, causing membrane disruption and inducing reactive oxygen species generation, which effectively hinders the development of resistance. Furthermore, the nanoparticles display strong synergistic interactions with conventional antifungals, significantly enhancing their efficacy. In addition to its planktonic activity, the system effectively inhibits biofilm formation and demonstrates high biocompatibility with human dermal cell lines. Based on these results, the nanodevice is successfully incorporated into a wound dressing matrix, demonstrating its promising translational potential for the topical treatment of cutaneous candidiasis., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2024-155683OB-C41, and PID2024-162542OB-I00 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-a way of funding Europe. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON). This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032), supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & centerdot;I1) and by Generalitat Valenciana. The study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER, Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012). M.R.-T. thanks MIU for his FPU grant (FPU21/03142). F.J.H. thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Miguel Servet" (CP24/00043).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SBA-15 mesoporous particles with adsorbed cresol red dye and functionalized with 3-aminopropyl groups: Materials properties and dye release studies

  • vara Fabjan, E.
  • Cerc Koro ec, R.
  • ifrer, K.
  • Sever kapin, A.
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Research in the field of sensing has focused on tailoring the responsiveness of materials through the variation in materials properties achieved via functionalization of the mesoporous matrix. pH indicator dyes capable of protonation/deprotonation reactions are known to display different forms, resulting in changes in colour. This research focused on the preparation of mesoporous substrates SBA-15 with integrated pH indicator dye o-cresolsulphonephtalein (cresol red) grafted with (3-aminopropy)trimethoxysilane (gaining functionalized-SBA-15 material) in order to gain a colour change response following release of the dye. UV-Vis reflectance and absorbance spectra were used to evaluate forms of cresol red. The textural properties, including specific surface area, pore size distribution and pore volume were evaluated using nitrogen sorption, and XRD analysis was conducted to evaluate crystallinity of the material and pore ordering. The presence of 3-aminopropyl groups was determined by thermal decomposition using TGA¿DSC/MS. The functionalized SBA-15 materials loaded with cresol red mostly retained ordering of the pores and showed a slight reduction in surface area. Functionalization changed the surface properties of the material. In the non-functionalized SBA-15, cresol red was present in both double (H2L) and single (HL¿) protonated forms, whereas in the functionalized SBA-15 the deprotonated L2¿form prevailed. Through desorption experiments cresol red was successfully desorbed from selected sample to different media. The change of colour caused by alterations in the form of the dye once released from the mesoporous silica material into the medium was confirmed. The form of cresol red released was determined by the pH of the medium., We acknowledge the financial support from the Slovenian Research and Innovation Agency through core research Programmes No. P2 0273 and No. P1 0134. This research was also supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy

  • Escriche-Navarro, Blanca
  • Garrido-García, Eva María
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Montoya-Méndez. Isabel |||0009-0003-7755-4853
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Due to the heterogeneity of the senescent phenotype and the lack of a universal biomarker of senescence, the targeting of senescent cells is still an unresolved challenge, and the elimination of senescent cells using specific drugs (senolytics) is still limited in clinical use due to the off-target effects and associated toxicities of current therapeutic strategies. In this study, the induction of senescence in human melanoma cells by palbociclib is found to lead to a senescent phenotype characterized by overexpression of the membrane protein dipeptidyl peptidase 4 (DPP4), previously identified only in ageing contexts. Based on this discovery, a nanoparticle targeting DPP4 overexpression in the senescent surfaceome is designed, synthesized, and characterized to target senescent cancer cells. The nanoparticle based on mesoporous silica is loaded with the senolytic navitoclax, coated with disulfide-containing poly(ethylene glycol) to generate a redox-sensitive gatekeeper (S-S-PEG), and functionalized with an antibody against the DPP4 protein. The ability of the nanoparticles to effectively detect and eliminate senescent cells was confirmed in vitro and in vivo using a mouse model of palbociclib-induced senescent in melanoma. The DPP4-targeted nanoparticle effectively reduces tumor growth and selectively removes senescent cells. Taken together, this study highlights the potential of surfaceome-targeted nanoparticles, as a clinically relevant strategy for improving senolytic therapies., This research was supported by projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe and by the ERC Advanced Grant Edison (101052997) . This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . This research was supported by CIBER (CB06/01/2012) , Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovacion. B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project "IFI19/00026", co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant (UP2021-036) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Natural antimicrobials synergistically coupled with nanomotors: An innovative strategy for biofilm eradication

  • Medaglia, Serena|||0000-0003-3537-9842
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marin-Ferrandis, Lucia
  • Amorós, Pedro
  • Marcos, MD
  • Diez-Sánchez, Paula
[EN] Biofilms are one of the most important problems occurring in industrial environments, especially in food industry. The possibility of foodborne disease outbreaks as a result of biofilm-food cross-contamination is a distinct concern, along with the substantial costs associated with food spoilage and biofilm control. Besides, despite daily cleaning and disinfection, many bacteria grow in machines and surfaces in food processing plants, some of them forming biofilms. A promising procedure for disinfection and biofilm elimination could be the use of hybrid antimicrobial nanomaterials endowed with motion (i.e., nanomotors). Herein, we report Janus nanoparticles based on the conjunction of platinum and mesoporous silica nanoparticles, functionalized with a derivative of a natural antimicrobial compound, vanillin. The engineered nanomotors combine H2O2-triggered self-propulsion with the antimicrobial activity of vanillin, allowing enhanced physical penetration into the 3D matrix formed by the exopolymeric substances generated in monospecies (Staphylococcus aureus) and multispecies (S. aureus and Escherichia coli) biofilms and the subsequent elimination of pathogenic cells., The Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22 and TED2021-132114B-I00, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia Innovacion) and the Generalitat Valenciana (CIPROM/2021/007) funded this research. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON) . This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032) , supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & sdot;I1) and by Generalitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149) . A<acute accent>.M.-A. thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22) . F.J.H thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021) . M.R.-T. thanks MIU for his FPU grant (FPU21/03142) . A.B. thanks the MIU for her Beatriz Galindo contract (BG20/00020) . P.D.thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120) and "Miguel Servet" (CP24/00043) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Mechanism of the Low-Temperature Organic Removal from Imidazolium-Containing Zeolites by Ozone Treatment: Fluoride Retention in Double-4-Rings

  • Rei Gao, Zihao
  • Márquez-Álvarez, Carlos
  • Rodríguez-Gómez Balestra, Salvador
  • Yu, Huajian
  • Camblor, Miguel A.
  • Villaescusa Alonso, Luis Angel|||0000-0002-2720-3217
[EN] For zeolites synthesized using imidazolium cations, the organic matter can be extracted at very low temperatures (100 °C) using ozone. This is possible for zeolites with 12-ring or larger pores but requires higher temperatures in medium-pore zeolites. The first chemical events in this process occur fast, even at room temperature, and imply the loss of aromaticity likely by the formation of an adduct between ozone and the imidazole ring through carbons C4 and C5. Subsequent rupture of the imidazole ring provides smaller and more flexible fragments that can desorb more readily. This process has been studied experimentally, mainly through infrared spectroscopy, and theoretically by density functional theory. Amazingly, fluoride anions occluded in the small double-four-ring units (d4r) during the synthesis remain inside the cage throughout the whole process when the temperature is not too high (¿150 °C). However, fluoride in larger cages in MFI ends up bonded to silicon in penta or hexacoordinated units, likely out of the cages, after ozone treatment at 150 °C. For several germanosilicate zeolites, the process allows their subsequent degermanation to yield stable high-silica zeolites. Quaternary ammonium cations require harsher conditions that eventually also extract fluoride from zeolite cages, including the d4r unit., Grants PID2019-105479RB-I00, PID2022-138481NB-I00, PID2022-137889OB-I00, TED2021-131223B-I00, PID2021-128141OB-C22, and FJC2018-035697-I were funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGeneration EU/PRTR. M.A.C. thanks J. C. van der Waals for sharing unpublished information on his pioneering work. H.Y. is grateful to the China Scholarship Council (CSC) for a Ph.D. fellowship. S.R.G.B. also thanks the Consejeria de Universidades, Investigacion e Innovacion, Junta de Andalucia, for the POSTDOC_21_00069 grant.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Synergistic antimicrobial photodynamic therapy using gated mesoporous silica nanoparticles containing curcumin and polymyxin B

  • Medaglia, Serena|||0000-0003-3537-9842
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Otri, Ismael
[EN] Photodynamic Therapy is a therapy based on combining a non-toxic compound, known as photosensitizer (PS), and irradiation with light of the appropriate wavelength to excite the PS molecule. The photon absorption by the PS leads to reactive oxygen species generation and a subsequent oxidative burst that causes cell damage and death. In this work, we report an antimicrobial nanodevice that uses the activity of curcumin (Cur) as a PS for antimicrobial Photodynamic Therapy (aPDT), based on mesoporous silica nanoparticles in which the action of the classical antibiotic PMB is synergistically combined with the aPDT properties of curcumin to combat bacteria. The synergistic effect of the designed gated device in combination with irradiation with blue LED light (470 nm) is evaluated against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus epidermidis. The results show that the nanodevice exhibits a noteworthy antibacterial activity against these microorganisms, a much more significant effect than free Cur and PMB at equivalent concentrations. Thus, 0.1 mu g/mL of MSNs-Cur-PMB eliminates a bacterial concentration of about 105 CFU/mL of E. coli, while 1 mu g/mL of MSNs-Cur-PMB is required for P. aeruginosa and S. epidermidis. In addition, antibiofilm activity against the selected bacteria was also tested. We found that 0.1 mg/mL of MSNs-Cur-PMB inhibited 99 % biofilm formation for E. coli, and 1 mg/mL of MSNs-CurPMB achieved 90 % and 100 % inhibition of biofilm formation for S. epidermidis and P. aeruginosa, respectively., This research was funded by the Spanish Government (projects PID2021-126304OB-C41 and PID2021-128141OB-C22, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion) and the Generalitat Valenciana, Spain (CIPROM/2021/ 007). This study forms part of the Advanced Materials programme (MFA/2022/053) and was supported by MCIN with funding from Eu ropean Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This study forms part of the AGROALNEXT programme (AGROALNEXT/2022/032) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Gen eralitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolía fellowship (GRISOLIAP/2018/149). I.O. thanks Erasmus Mun dus Programme, Action 2, Lot 1, Syria, for his predoctoral fellowship. A. B. thanks the Ministerio de Universidades (Spanish Government) for her Beatriz Galindo contract (BG20/00020).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Nanodevice-Mediated Immune Cell Recruitment: Targeting Senescent Cells via MMP-3-Responsive CXCL12-Coated Nanoparticles

  • Escriche-Navarro, Blanca
  • Labernadie, Anna
  • Garrido-García, Eva María
  • Clara-Trujillo, Sandra|||0000-0002-6455-2993
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Senescent cells are involved in age-related disorders in different organs and are therapeutic targets for fibrotic and chronic pathologies. Immune-modulating agents, able to enhance senescent cell detection and elimination by endogenous immune cells, have emerged as pharmacological strategies. We report herein a nanoparticle for immune cell-mediated senolytic therapy designed to recruit immune cells in response to specific enzymatic matrix metalloproteinase-3 (MMP-3) activity in the senescence-associated secretory phenotype. For this, mesoporous silica nanoparticles (MSNs) are coated with a peptide substrate of the metalloproteinase MMP-3, and the peptide is decorated with chemokine CXCL12 that enhances immune cell recruitment (NPs@CXCL12). Controlled release studies confirmed the progressive and specific release of CXCL12 in the presence of MMP-3. The ability of immune cell recruitment in response to a senescent microenvironment (senescent WI-38 fibroblasts) is confirmed by Transwell migration assays with green fluorescent Jurkat T-cells, showing NPs@CXCL12 has an enhanced chemotaxis effect toward senescent cells compared to free CXCL12 (2-fold). Moreover, the cytotoxic capacity of human primary natural killer (NK) cells over senescent WI-38 is also confirmed, and their migration trajectories in response to NPs@CXCL12 or free CXCL12 are monitored by using a microfluidic device. Results confirm the ability of NPs@CXCL12 to generate a chemotactic gradient able to attract NK cells. When compared with free CXCL12, the NPs@CXCL12 system showed a reduction of up to 15.56% in the population of NK cells migrating toward free CXCL12 under competitive conditions. This study demonstrates the potential of designing nanoparticles to recruit immune cells under specific responses to eliminate senescent cells. Results confirm that NPs@CXCL12 can effectively establish a chemotactic gradient to attract NK cells., This research was supported by projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by the European Regional Development FundyA way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012), Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovacion. A.L. is grateful to the RYC2020/029736/I grant and PID2021-125212OA-I00 project funded by MCIN. B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project "IFI19/00026", cofunded by the European Union and the company Senolytic Therapeutics S.L. for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Preserving Heritage Spaces by a Tea Tree Oil-Loaded Silica Microparticles System for Air Purification

  • Tassi, Anna Laura
  • Cebriá-Mendoza, María Concepción
  • Pinna, Daniela
  • Santiglia, Alessia
  • Santagostini, Laura
  • Guglielmi, Vittoria
  • Bosch-Roig, Pilar|||0000-0003-2019-399X
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Featured Application This research aims to develop a cost-effective and easy-to-use technology for improving indoor air quality through the reduction of fungal and bacterial contamination. While the primary objective of the project is the conservation of cultural heritage, the proposed tool also has broader applications as a passive air purification system for residential and occupational settings, contributing to healthier indoor environments by lowering harmful microbial loads.Abstract Airborne fungi and bacteria pose a severe challenge for conservators, as they can settle on artistic surfaces, leading to chemical, physical and aesthetic degradation of artworks. A new air-cleaning system has been developed to reduce indoor airborne microorganisms by leveraging the antimicrobial potential of Tea Tree (Melaleuca alternifolia) Essential Oil (TTEO) encapsulated within the pores of MCM-41 mesoporous silica microparticles (MCM-TTEO), thereby extending its antimicrobial activity and enhancing its efficacy. Experimental data showed a progressive release of TTEO from the MCM-TTEO system during the 5 weeks monitoring. The release rate was quite linear in the first week, reaching about 16.2%, before plateauing at approximately 30% in the next weeks. A comparison of the performances of the MCM-TTEO system with those of the non-encapsulated ('free') TTEO was performed using a comprehensive air quality monitoring approach, which tracked temperature, relative humidity, microbial loads and particulate matter. Results demonstrate that the MCM-TTEO system maintained higher biocidal activity over the 5-week study period than the free EO. Furthermore, the biocidal efficacy increased when the MCM-TTEO system was used in direct contact with microorganisms. These promising findings highlight the potential for exploring different combinations of the two components in both passive and active configurations, including the development of air filtration systems., Erasmus + Placement 2023/2024 Scholarship funded A.L.T. staying in Valencia and the Santos Juanes Project funds the lab fungible material. This research was funded by the Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2024-155683OB-C41 and PID2024-162542OB-I00), MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion and the Generalitat Valenciana (CIPROM/2021/007).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Photothermic Release of Curcumin for Antimicrobial Photodynamic Therapy

  • Trigo-Gutierrez, Jeffersson K.
  • G. O. Mima, Ewerton
  • Medaglia, Serena|||0000-0003-3537-9842
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Drug delivery systems (DDS) are promising tools to enhance antimicrobial Photodynamic Therapy (aPDT) by improving the targeted delivery and controlled release of photosensitizers. In this study, we introduce a light-responsive DDS based on curcumin-loaded mesoporous silica nanoparticles featuring a gold nanostar core and paraffin capping, designed specifically for near-infrared (NIR)-triggered photothermal release. This multicomponent nanoplatform uniquely combines photothermal activation with light-controlled drug delivery for antimicrobial applications. The synthesized nanoparticles exhibited a mean diameter below 500 nm, a polydispersity index of 0.154, and a surface charge of ¿21.9 mV. Upon NIR irradiation at 1200 J/ cm2 , curcumin release was approximately 90%. In planktonic bacterial cultures, aPDT mediated by this system led to reductions of 3.16 log10 and 2.18 log10 in colony-forming units (CFUs) for Staphylococcus aureus and Pseudomonas aeruginosa, respectively. For bacterial biofilms, a higher curcumin concentration (1000 ¿g/mL) resulted in CFU reductions of 2.16 log10 and 1.77 log10 for S. aureus and P. aeruginosa, respectively. This study demonstrated a NIR-activated nanocarrier for the controlled release of curcumin and effective inactivation of both planktonic and biofilm-associated bacteria offering a new approach to improve the precision and efficacy of aPDT., J.K.T.-G. received a PhD sandwich scholarship from the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES-PrInt-Unesp Program, process #88887.3636622/2019-00). E.G.O.M. was funded by SPRINT FAPESP 2019/08884-1, RIDC 13/07276-1, CNPq/INCT 14/50857-8. This research was also supported through projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund A Way of Doing Europe and by the Generalitat Valenciana (CIPROM/2021/007).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Systematic study of the implications of calcination and solvent extraction of the surfactant in MCM-41-type mesoporous silica nanoparticles

  • Candela-Noguera, Vicente
  • Aznar, Elena|||0000-0003-0361-3876
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Amorós, Pedro
[EN] Mesoporous silica nanoparticles (MSN) have been growing in recent years in a broad range of applications, such as nanomedicine, catalysis, and gas storage. For the preparation of MSN, especially in nanomedicine applications, the extraction of the surfactant template, generally 1-hexadecyltrimethylammonium bromide (CTAB), is required. Several methods to remove the surfactant from MNS have been reported in the literature, such as calcination, solvent extraction, and dialysis. Depending on the method employed, the materials obtained have different properties; however, a systematic study that compares the use of different surfactant extraction methods and their implications in the final characteristics of the MSN has not been reported. Hence, the aim of this work is to study the effect of surfactant removal on MSN by calcination at different temperatures (400 degrees C, 450 degrees C, 500 degrees C and 550 degrees C) or by extraction with HCl/ethanol or NH 4 NO 3 /ethanol. The final materials are fully characterised by different techniques. The study performed shows the removal efficiency when the different methods are used, and their effect on silica condensation degree, mesoporosity, cytotoxicity, and degradation rate. The results allow for obtaining a deeper knowledge of the surfactant removal processes., V.C.-N. thanks the Spanish Government for his fellowship (FPU15/02753) . This research was supported by projects PID2021-126304OB-C41, PID2021-126304OB-C43 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-Away of doing Europe. This study also forms part of the Advanced Materials programme (MFA/2022/049 and MFA/2022/053) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . This research was also supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB07/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. The authors also thank the Electron Microscopy Service at UPV and SCSIE at UV for support. NMR was registered at the U26 facility of ICTS "NANBIOSIS" at the Universitat of Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Covalent organic frameworks as nanocarriers of tailored BODIPY for phototheragnostic applications

  • Jimenez-Duro, Miguel
  • Soler-Beatty, Jennifer
  • Martinez-Fernandez, Marcos
  • Avellanal-Zaballa, Edurne
  • Martinez, Jose I.
  • Ortiz, Maria J.
  • Duran-Sampedro, Gonzalo
  • Banuelos, Jorge
  • Segura, Jose L.
  • Soriano-Teruel, Paula
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Grafting fluorophores and photosensitizers onto nanocarriers is recognized as an effective strategy for fluorescent bioimaging and photodynamic therapy. This approach enhances targeted drug delivery to tumor sites, while improving the biocompatibility and stability of poorly water-soluble bioprobes, thereby reducing side effects. Among the available organic dyes and nanoparticles, BODIPY and COF stand out as a compatible pair for this purpose. To leverage the COF-BODIPY scaffold as a photoactive platform for biomedical applications, we have optimized their integration. To this aim, first, BODIPY units were functionalized to enable strong binding to specific sites of the COF via click chemistry, positioning the BODIPY within the pores of the COF. Following this approach, BODIPY derivatives photoactive across different spectral regions (from the green to the red window) were straightforwardly grafted onto the COF. The structural and photophysical properties of these nanomaterials were thoroughly characterized. Notably, the COF bearing styrylated and iodinated BODIPY was especially appealing due to its dual photonic performance, enabling both singlet oxygen generation and red fluorescence under long-wavelength excitation. Upon its cellular uptake by human melanoma cells, this dyed nanoparticle selectively stained lysosomes, and at the same time triggered a cytotoxic response to induce cell death under illumination with red light, thus being a suitable candidate for theragnostic purposes., This research was supported by projects: TED2021-129886B-C43 granted by MCIN/AEI/10.13039/501100011033 and the European Union NextGeneration EU/PRTR; PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe; PID2022-138908NB-C33 and PID2024-157648-NB-C22 granted by MICIU/AEI/10.13039/501100011033 and FEDER, UE. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) and Gobierno Vasco (IT1639-22). The work was supported by CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. J. L. S. acknowledges the MICIIN for the REDES project "RED2022-134503-T". P. M. S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). J. I. M. acknowledges funding from Spanish MCIN (Grants PID2023-149077OB-C31, TED2021-12941A-I00 and PLEC2021-007906 funded by MCIN/AEI/10.13039/501100011033 and by the "European Union NextGenerationEU/PRTR"), and Comunidad de Madrid (Grant TEC-2024/TEC-459). The Severo Ochoa Centres of Excellence program through Grant CEX2024-001445-S is also acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeted Delivery of the Pan-Inflammasome Inhibitor MM01 as an Alternative Approach to Acute Lung Injury Therapy

  • García-Fernández, Alba|||0000-0002-8416-1674
  • Garrido-García, Eva María
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancho, Mónica
  • Bisbal, Viviana
  • Orzáez, Mar
[EN] Acute lung injury (ALI) is a severe pulmonary disorder responsible for high percentage of mortality and morbidity in intensive care unit patients. Current treatments are ineffective, so the development of efficient and specific therapies is an unmet medical need. The activation of NLPR3 inflammasome during ALI produces the release of proinflammatory factors and pyroptosis, a proinflammatory form of cell death that contributes to lung damage spreading. Herein, it is demonstrated that modulating inflammasome activation through inhibition of ASC oligomerization by the recently described MM01 compound can be an alternative pharmacotherapy against ALI. Besides, the added efficacy of using a drug delivery nanosystem designed to target the inflamed lungs is determined. The MM01 drug is incorporated into mesoporous silica nanoparticles capped with a peptide (TNFR-MM01-MSNs) to target tumor necrosis factor receptor-1 (TNFR-1) to proinflammatory macrophages. The prepared nanoparticles can deliver the cargo in a controlled manner after the preferential uptake by proinflammatory macrophages and exhibit anti-inflammatory activity. Finally, the therapeutic effect of MM01 free or nanoparticulated to inhibit inflammatory response and lung injury is successfully demonstrated in lipopolysaccharide-mouse model of ALI. The results suggest the potential of pan-inflammasome inhibitors as candidates for ALI therapy and the use of nanoparticles for targeted lung delivery., This research was supported by Project Nos. PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2020-115048RB-I00 funded by MCIN/AEI/10.13039/501100011033 and by European Regional Development Fund - A way of doing Europe. The authors also thank Generalitat Valenciana (PROMETEO Project CIPROM/2021/007 and PROMETEO 2019/065) for support. E.G. is grateful to the Spanish MIU and European Union-Next Generation EU for her "Margarita Salas" postdoctoral grant (UP2021-036). The authors would also like to thank Animal Facilities from Centro de Investigacion Principe Felipe for its support in the animal research and procedures, and I. Borred and J. Forteza from Instituto Valenciano de Patologia for its technical support in the histopathology analysis. The authors thank for the use of Biorender.com in the figures and graphical abstract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells

  • Escriche-Navarro, Blanca
  • Garrido-García, Eva María
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cellular senescence is implicated in the occurrence and progression of multiple age-related disorders. In this context, the selective elimination of senescent cells, senolysis, has emerged as an effective therapeu- tic strategy. However, the heterogeneous senescent phenotype hinders the discovery of a universal and robust senescence biomarker that limits the effective of senolytic with off-target toxic effects. Therefore, the development of more selective strategies represents a promising approach to increase the specificity of senolytic therapy. In this study, we have developed an innovative nanodevice for the selective elimi- nation of senescent cells (SCs) based on the specific enzymatic activity of the senescent secretome. The results revealed that when senescence is induced in proliferating WI-38 by ionizing radiation (IR), the cells secrete high levels of matrix metalloproteinase-3 (MMP-3). Based on this result, mesoporous silica nanoparticles (MSNs) were loaded with the senolytic navitoclax (Nav) and coated with a specific peptide which is substrate of MMP-3 (NPs(Nav)@MMP-3). Studies in cells confirmed the preferential release of cargo in IR-induced senescent cells compared to proliferating cells, depending on MMP-3 levels. More- over, treatment with NPs(Nav)@MMP-3 induced a selective decrease in the viability of SCs as well as a protective effect on non-proliferating cells. These results demonstrate the potential use of NPs to develop enhanced senolytic therapies based on specific enzymatic activity in the senescent microenvironment, with potential clinical relevance., This research was supported by projects PID2021-126304OBC41 and PID2021-128141OB-C22 funded by MCIN/ AEI /10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER (CB06/01/2012), Instituto de Salud Carlos III and Ministerio de Ciencia e Innovación. This work was also supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project IFI19/00026 , co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her Margarita Salas postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chitosan nanoparticles-encapsulated cannabis extracts and their antimicrobial potential against skin pathogens

  • Skala, Tomas
  • Frankova, Adela
  • Tauchen, Jan
  • Kahankova, Zdenka
  • Hubka, Vít
  • Kloucek, Pavel
  • Ventura-Cobos, Jordi|||0000-0001-8475-9820
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
[EN] Cannabis compounds are well-known for their therapeutic applications in the treatment of various health issues. These substances, mainly cannabinoids, are known for their antimicrobial properties and ability to interact with various cells through endocannabinoid receptors. However, the limitations of cannabis extract, particularly its viscosity, stickiness, and low bioavailability when applied topically, limit its use in dermatology. To enhance topical applications for treating bacterial infections and dermatophytosis, cannabis extracts were encapsulated in chitosan nanoparticles, an easily accessible and cost-effective. Cannabis extracts were prepared from three cannabis strains differing in content of major cannabinoids, namely Chocolope (THCA-A), Jonas 1 (CBDA), and Hemp G (CBGA), and subsequently were encapsulated in chitosan nanoparticles. The resulting particles were characterized, and antimicrobial and cytotoxic activity was evaluated. The mean size of particles ranged from 89.1 +/- 24.8 nm for empty nanoparticles to 355.6 +/- 101.6 nm for particles containing Hemp G extract. Considering the extract:chitosan ratio (1:10 w/w, 1:20 w/w respectively) and the encapsulation efficiency (EE) range from 44.65 +/- 4.39% to 94.44 +/- 0.93%, total amount of extracts encapsulated in chitosan nanoparticles ranged from 2.96 +/- 0.05 to 5.61 +/- 0.19% in 1 g of chitosan nanopowder. Most significant antimicrobial effect was observed against the fungi Nannizzia fulva CCF 6025, where the MIC80 of the pure extract from Jonas 1 variety was 256 mu g/mL while the encapsulated extract in chitosan nanoparticles (1:10 w/w extract:chitosan ratio) inhibited growth at a concentration of 256 mu g/mL of nanoparticles (corresponding to 13.05 +/- 0.13 mu g/mL of extract). Overall, encapsulation reduced the amount of extract required to inhibit the growth of pathogenic microorganisms by up to several times, notably in case of dermatophytes, compared to non-encapsulated extracts. Encapsulation also reduced the cytotoxic effects of the extracts on human keratinocytes. Furthermore, pure high-THCA-A extract and encapsulated extract in chitosan nanoparticles slightly increased cell viability after 72 h exposure in low concentrations compared to control. These results may suggest the chitosan nanoparticles-encapsulated formulations as a suitable topical delivery form of cannabis extracts, offering a possible adjunctive treatment of dermatophytosis and wound healing., The author(s) declare that financial support was received for the research and/or publication of this article. The work used facilities provided by the METROFOOD-CZ Research Infrastructure (https://metrofood.cz), supported by the Ministry of Education, Youth and Sports of the Czech Republic (Project No. LM2023064). This research was supported by SGS project No. SV23-18-21310 and TACR Sigma -DC2 TQ03000678. The authors would like to acknowledge the support from the Spanish Ministry of Science and Innovation, AEI, and FEDER-EU (projects PID2021-128141OB-C22 and PID2021-126304OB-C41). AM-A thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). AL-L thanks the Spanish Government for his "Ramon y Cajal" Fellowship (RYC2021-034728-I).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chemical characterization and encapsulation of &lt, i&gt, Ganoderma pfeifferi&lt, /i&gt, extract with cytotoxic properties

  • Stastny, Jan
  • Skala, Tomas
  • Marsik, P.
  • Lerida-Viso, Araceli
  • Matejka, Jaroslav
  • Mascellani Bergo, Anna
  • Marcos, María Dolores
  • Jablonsky, Ivan
  • Kloucek, Pavel
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Mushrooms of the genus Ganoderma are known for diverse biological activities, demonstrated both traditionally and experimentally. Their secondary metabolites have shown cytotoxic potential across different cancer cell lines. Besides exploration of the most active components in different species or genotypes, new formulation techniques are in development. In recent years, there has been a growing interest in the use of nanomaterials because of significant potential for pharmacology applications as substance carriers. Applying nanoparticles may enhance the medicinal effect of the mushroom substances. This study investigated the cytotoxic properties of Ganoderma species methanolic extracts against the HeLa cancer cell line. Notably, the extract obtained from Ganoderma pfeifferi demonstrated the highest activity and was further used for encapsulation within synthesized mesoporous silica nanoparticles MCM-41. Subsequently, the cytotoxic effect of the loaded MCM-41 to the free form of extract was compared. The obtained results indicate successful encapsulation, and similar activity comparing encapsulated form to free extracts (IC50 16.6 mu g/mL and 20.5 mu g/mL, respectively). In addition, the four unique compounds were identified as applanoxidic acid A, applanoxidic acid G, ganoderone A, and ganoderone B in the G. pfeifferi. This study is an essential prerequisite for further steps like nanoparticle functionalization for sustained or on-command delivery of these natural extracts., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was funded by the National Agency for Agricultural Research of the Ministry of Agriculture of the Czech Republic under project number QK1910209; by the Research Infrastructure METROFOOD-CZ supported by the Ministry of Education, Youth, and Sports of the Czech Republic under project number LM2023064). This research was supported by projects PID 2021-126304OB-C41 and PID 2021- 128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund- A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. A.M.-A. thanks to the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). AB. thanks the MCIN for her BG20/00020 contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Antimicrobial Surfaces: Stainless Steel Functionalized with the Essential Oil Component Vanillin

  • Medaglia, Serena|||0000-0003-3537-9842
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Villaescusa Alonso, Luis Angel|||0000-0002-2720-3217
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Morella-Aucejo, Angela
  • Ruiz Rico, María
  • Martínez-Manez, Ramón
[EN] Pathogenic microorganisms can adhere to solid surfaces, leading to the formation of biofilms, thus building a physical barrier hindering the penetration and diffusion of antimicrobial compounds. In this context, the use of natural antimicrobial compounds, such as essential oil components, as substitutes for common synthetic antimicrobials in the fight to prevent antimicrobial resistance is explored. As stainless steel is one of the most widely used surfaces in different industries, we have developed an innovative antimicrobial treatment for stainless steel surfaces based on a multi-step functionalization process, in which the stainless steel surface is coated with a silica layer to which a vanillin derivative is covalently attached. The surface was analyzed by microscopy studies, indicating the correct immobilization on the surfaces. Antimicrobial studies (viability and bacterial adhesion assays) were performed against the bacteria Staphylococcus epidermidis, which is one of the most frequent causes of nosocomial infections. The results of the microbiological studies showed that vanillin-functionalized stainless steel surfaces reduce the bacteria viability by 100% and the biofilm formation on the stainless steel surface by 75% compared with non-functionalized surfaces, highlighting the contact-killing and adhesion resistance properties of the developed surface. Additional cycles using the functionalized surfaces showed good maintenance of the antimicrobial coating efficacy. Moreover, the surfaces coated with an intermediate silica layer demonstrated much greater antimicrobial activity than surfaces in which the active molecule was directly functionalized on the stainless steel surface., This research was supported by the projects PID2021-126304OB-C41 and PID2021-128141OB-C22, funded by the MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund-A way of doing Europe. This study was also supported by the Generalitat Valenciana (CIPROM/2021/007). This research was supported by the CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. This study formed part of the Advanced Materials program (MFA/2022/053) and was supported by the MCIN, with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by the Generalitat Valenciana. This study formed part of the AGROALNEXT program (AGROALNEXT/2022/032) and was supported by the MCIN, with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by the Generalitat Valenciana. This study formed part of the THINKINAZUL program (THINKINAZUL/2021/004) and was supported by the MCIN, with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by the Generalitat Valenciana. This research was also supported by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 814607 (SAFE-N-MEDTECH project). S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149). & Aacute;.M.-A. thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). A.B. thanks the MCIN for her BG20/00020 contract and her PAID-PD-22 project funded by the UPV.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Remarkable enhancement of cinnamaldehyde antimicrobial activity encapsulated in capped mesoporous nanoparticles: A new &quot, nanokiller&quot, approach in the era of antimicrobial resistance

  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Medaglia, Serena|||0000-0003-3537-9842
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Ruiz Rico, María
[EN] Combating antimicrobial resistance is one of the biggest health challenges because of the ineffectiveness of standard biocide treatments. This challenge could be approached using natural products, which have demonstrated powerful therapeutics against multidrug-resistant microbes. In the present work, a nanodevice consisting of mesoporous silica nanoparticles loaded with an essential oil component (cinnamaldehyde) and functionalized with the polypeptide epsilon-poly- L -lysine is developed and used as an antimicrobial agent. In the presence of the corresponding stimuli (i.e., exogenous proteolytic enzymes from bacteria or fungi), the polypeptide is hydrolyzed, and the cinnamaldehyde delivery is enhanced. The nanodevice's release mechanism and efficacy are evaluated in vitro against the pathogenic microorganisms Escherichia coli , Staphylococcus aureus , and Candida albicans . The results demonstrate that the new device increases the delivery of the cinnamaldehyde via a biocontrolled uncapping mechanism triggered by proteolytic enzymes. Moreover, the nanodevice notably improves the antimicrobial efficacy of cinnamaldehyde when compared to the free compound, ca. 52-fold for E. coli , ca. 60fold for S. aureus , and ca. 7-fold for C. albicans . The enhancement of the antimicrobial activity of the essential oil component is attributed to the decrease of its volatility due to its encapsulation in the porous silica matrix and the increase of its local concentration when released due to the presence of microorganisms., This research was supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. This work was also funded by the Generalitat Valenciana and Agencia Valenciana de la Innovacion (MCIN) (INNEST/2021/169 project) and is susceptible to be co-founded by the European Union. <acute accent> A. M.-A. thanks to the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22) . A.B. thanks the MCIN for her BG20/00020 contract and her PAID-PD-22 project funded by UPV.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Stable Silica-Based Zeolites with Three-Dimensional Systems of Extra-Large Pores

  • Yu, Huajian
  • Gao, Zihao Rei
  • Camblor, Miguel A.
  • Villaescusa Alonso, Luis Angel|||0000-0002-2720-3217
[EN] Zeolites are microporous crystalline materials that find a very wide range of applications, which, however, are limited by the size and dimensionality of their pores. Stable silica zeolites with a three-dimensional (3D) system of extra-large pores (ELP, i.e., pores with minimum windows along the diffusion path consisting of more than 12 SiO4/2 tetrahedra, 12R) are in demand for processing larger molecules than zeolites can currently handle. However, they have challenged worldwide synthetic capabilities for more than eight decades. In this review we first present a brief history of the discovery of ELP zeolites. Next, we show that earlier successes of zeolites with 3D ELP were not actually zeolites, but rather interrupted structures with, in addition, a composition that severely detracted from their stability. Finally, we present three new fully connected stable silica-based 3D ELP zeolites ZEO-1, ZEO-3 and ZEO-5, discuss their preparation methods and stability as well as the clear advantage of their increased porosity in catalysis and adsorption processes involving large molecules. We will discuss peculiar characteristics of their preparation and present two new reaction types giving rise to zeolites (1D-to-3D topotactic condensation and interchain expansion), highlighting how new synthesis methods can provide materials that would otherwise be unfeasible., Financial support from the Spanish Ministry of Science Innovation (PID2022-137889OB-I00, PID2021-128141OB-C22, TED2021-131223B-I00, MCIN/AEI/10.13039/501100011033), and Generalitat Valenciana (PROMETEO CIPROM/2021/007) are gratefully acknowledged. H.Y. is grateful to the China Scholarship Council for a PhD grant.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In Vivo Study of Osseointegrable Bone Calcium Phosphate (CaP) Implants Coated with a Vanillin Derivative

  • Medaglia, Serena|||0000-0003-3537-9842
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Bernabe-Quispe, Patricia
  • Tomás-Chenoll, Julia
  • Cebriá-Mendoza, María Concepción
  • Tormo-Mas, Maria Angeles
  • Primo Capella, Victor
  • Peris-Serra, José-Luis
[EN] Background/Objectives: Orthopaedic infections associated with implant surgery remain a major public health concern, often caused by bacterial colonization of implant surfaces. Staphylococcus epidermidis is among the most common pathogens involved. Developing antimicrobial bone implants that prevent infection without compromising bone regeneration is therefore essential. This study investigates the antimicrobial and osteointegrative performance of calcium phosphate (CaP) materials functionalized with vanillin, an essential oil component with known antimicrobial properties. Methods: Commercial CaP regenerative materials were covalently coated with vanillin. Antibacterial activity was evaluated against Staphylococcus epidermidis RP62A using viability assays. In vivo osseointegration was assessed in New Zealand female rabbits implanted with vanillin-coated and uncoated CaP scaffolds. Results: Vanillin-functionalized CaP scaffolds exhibited strong bactericidal activity at 24 h and bacteriostatic effects at 48 h at a concentration of 10 mg/mL. In vivo analyses showed no significant differences in osseointegration between vanillin-coated implants and control CaP materials. Conclusions: Vanillin-functionalized CaP materials maintain a high safety profile without impairing bone integration, supporting their potential use in clinical applications., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2021-122875OB-100, PID2024-155683OB-C41 and PID2024-162542OB-I00 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-a way of funding Europe. Also, this study forms part of the Advanced Materials programme (MFA/2022/053) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. The study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012) and MICRO-STOP project, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. All figures done with BioRender.com. S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149). M.C-M thanks the Generalitat Valenciana for the postdoctoral contract (INVEST/2022/381). Part of the equipment used to develop this work was supported by Generalitat Valenciana (IDIFEDER/2021/044) and is susceptible to be co-founded through the Operational Programme of the European Regional Development Fund. The authors also thank the Electron Microscopy Service at UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Toxicological Profiling and Long-Term Effects of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles

  • Barguilla, Irene
  • Oliver, Patrick
  • Annangi, Balasubramanyan
  • Diez-Sánchez, Paula
  • Marcos, R.
  • Hernández, A.
  • Candela-Noguera, Vicente
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
[EN] Mesoporous silica nanoparticles (MSNs) are amongst the most used nanoparticles in biomedicine. However, the potentially toxic effects of MSNs have not yet been fully evaluated, being a controversial matter in research. In this study, bare MSNs, PEGylated MSNs (MSNs-PEG), and galacto-oligosaccharide-functionalized MSNs (MSNs-GAL) are synthesized and characterized to assess their genotoxicity and transforming ability on human lung epithelial BEAS-2B cells in short- (48 h) and long-term (8 weeks) exposure scenarios. Initial short-term treatments show a dose-dependent increase in genotoxicity for MSNs-PEG-treated cells but not oxidative DNA damage for MSNs, MSNs-PEG, or for MSNs-GAL. In addition, after 8 weeks of continuous exposure, neither induced genotoxic nor oxidative DNA is observed. Nevertheless, long-term treatment with MSNsPEG and MSNs-GAL, but not bare MSNs, induces cell transformation features, as evidenced by the cell¿s enhanced ability to grow independently of anchorage, to migrate, and to invade. Further, the secretome from cells treated with MSNs and MSNs-GAL, but not MSNs-PEG, shows certain tumor-promoting abilities, increasing the number and size of HeLa cell colonies formed in the indirect soft-agar assay. These results show that MSNs, specifically the functionalized ones, provoke some measurable adverse effects linked to tumorigenesis. These effects are in the order of other nanomaterials, such as carbon nanotubes or cerium dioxide nanoparticles, but they are lower than those provoked by some approved drugs, such as doxorubicin or dexamethasone., This work was supported by PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2020-116789RB-C43 funded by MCIN/AEI/10.13039/501100011033/, by the European Regional Development Fund "A way of doing Europe", by Generalitat Valenciana (CIPROM/2021/007), and by the Generalitat de Catalunya (2021-SGR-00731). The work was also supported by CIBER "Consorcio Centro de Investigación Biomédica en Red" (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. This study forms part of the Advanced Materials programme (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and from Generalitat Valenciana. This project has also received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 965196. Alba Hernández was granted an ICREA ACADEMIA award. Vicente Candela-Noguera thanks the Spanish Government for his fellowship (FPU15/02753). Paula Díez thanks the Generalitat Valenciana for her contract APOSTD/2020/153 and thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support `Sara Borrell¿, CD20/00120. The authors thank the Electron Microscopy Service at UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Remodeling the tumor immune microenvironment with lipid nanoparticles

  • Martínez-Latorre, Javier|||0000-0001-5421-5371
[ES] Esta tesis doctoral, titulada "Remodelación del microambiente inmunitario tumoral con nanopartículas lipídicas", explora el desarrollo de nuevas estrategias inmunoterapéuticas contra el cáncer, tanto a nivel terapéutico como de métodos de administración. En concreto, el trabajo investiga enfoques alternativos y relativamente poco explorados, como las inmunoterapias basadas en macrófagos y la inmunoterapia mediada por antígenos exógenos, que tratan de superar las principales limitaciones de las modalidades inmunoterapéuticas actuales. Paralelamente, la tesis evalúa las nanopartículas lipídicas (LNP) como sistemas de administración de genes no virales para la inmunoterapia. El primer capítulo experimental describe el desarrollo de una novedosa plataforma LNP para la inmunoterapia basada en macrófagos. Las LNP cargadas con ADN plasmídico o ARNm de luciferasa se funcionalizaron con ácido fólico (FA) para dirigirse a las células cancerosas pancreáticas que expresan el receptor de folato y con un anticuerpo anti-CD47 (aCD47) para bloquear la evasión inmunitaria mediada por CD47. Los resultados demuestran una transfección eficaz de las células de cáncer de páncreas, con las LNP cargadas con ARNm superando a las formulaciones basadas en plásmidos. Además, la funcionalización con FA mejoró la captación dirigida de LNP in vitro y la funcionalización con aCD47 restauró la fagocitosis de las células tumorales por los macrófagos in vitro. Los experimentos in vivo en modelos de xenoinjertos Capan-2 de ratón con LNP-ARNm-FA-aCD47 demostraron la expresión in vivo de luciferasa y promovieron un cambio hacia un fenotipo de macrófagos proinflamatorio M1 dentro del microambiente tumoral. En conjunto, estos resultados presentan una plataforma LNP optimizada, capaz de inmunomodular los macrófagos asociados a tumores. El segundo capítulo experimental presenta una novedosa inmunoterapia mediada por antígenos exógenos basada en el epítopo alpha-Gal (galactosa-alpha-1,3-galactosa). El epítopo alpha-Gal es altamente inmunogénico en humanos y provoca fuertes respuestas debido a anticuerpos preexistentes. Se desarrollaron LNP que codifican el ARNm de la alpha-1,3-galactosiltransferasa (alpha-GT) para permitir la biosíntesis endógena de alpha-Gal en la superficie de las células tumorales. El tratamiento con estas LNP indujo con éxito la expresión de alpha-Gal en líneas celulares cancerosas murinas y humanas y promovió el reclutamiento de anticuerpos anti-alpha-Gal humanos naturales hacia las células tumorales. Estos resultados identifican a la LNP alpha como una plataforma inmunoterapéutica prometedora que aprovecha la inmunidad humoral preexistente. El tercer capítulo experimental describe una novedosa inmunoterapia mediada por antígenos exógenos basada en la proteína hemaglutinina (H) del virus del sarampión. La proteína H es un antígeno altamente inmunogénico en humanos debido a la vacunación generalizada contra el virus del sarampión. Se formularon LNP que codifican la proteína H y se demostró que transfectan eficazmente tanto cultivos celulares cancerosos bidimensionales como esferoides tumorales tridimensionales. Además, la administración in vivo de LNP H en ratones vacunados contra el sarampión con tumores de melanoma B16-BL6 dio lugar a una disminución significativa del crecimiento tumoral. Este efecto terapéutico está asociado con una fuerte infiltración intratumoral de linfocitos T citotóxicos CD8+, un cambio en la proporción de células T CD8/CD4 y la producción ex vivo de citocinas proinflamatorias tras la reactivación del antígeno, características distintivas de una potente respuesta inmunitaria mediada por células T CD8+. En conjunto, estos resultados ponen de relieve el potencial de LNP H como nueva estrategia para mejorar la inmunogenicidad tumoral y provocar fuertes respuestas inmunitarias antitumorales., [EN] This doctoral thesis, entitled "Remodeling the Tumor Immune Microenvironment with Lipid Nanoparticles", explores the development of novel cancer immunotherapeutic strategies at both the therapeutic and delivery levels. Specifically, the work investigates alternative and comparatively underexplored approaches, including macrophage-based immunotherapies and exogenous antigen-mediated immunotherapy, which seek to overcome key limitations of current immunotherapeutic modalities. In parallel, the thesis evaluates lipid nanoparticles (LNPs) as non-viral gene delivery systems for immunotherapy. The first experimental chapter describes the development of a novel LNP platform for macrophage-based immunotherapy. LNPs loaded with either luciferase-encoding plasmid DNA or mRNA were functionalized with folic acid (FA) for targeting folate receptor-expressing pancreatic cancer cells and with an anti-CD47 antibody (aCD47) to block CD47-mediated immune evasion. The results demonstrate efficient transfection of pancreatic cancer cells, with mRNA-loaded LNPs outperforming plasmid-based formulations. Moreover, the functionalization with FA enhanced targeted uptake of LNPs in vitro and aCD47 functionalization restored the phagocytosis of tumor cells by macrophages in vitro. In vivo experiments in mouse Capan-2 xenograft models with LNP-mRNA-FA-aCD47 demonstrated in vivo expression of luciferase and promoted a shift to a pro-inflammatory, M1-like macrophage phenotype within the tumor microenvironment. Together, these results present an optimized LNP platform capable of immunomodulating tumor-associated macrophages. The second experimental chapter presents a novel exogenous antigen-mediated immunotherapy based on the alpha-Gal epitope (galactose-alpha-1,3-galactose). alpha-Gal epitope is highly immunogenic in humans and elicits strong pre-existing antibody responses. LNPs encoding alpha-1,3-galactosyltransferase (alpha-GT) mRNA were developed to enable endogenous alpha-Gal biosynthesis on tumor cell surfaces. Treatment with these LNPs successfully induced alpha-Gal expression in both murine and human cancer cell lines and promoted the recruitment of naturally occurring human anti-alpha-Gal antibodies to tumor cells. These results identify LNP alpha as a promising immunotherapeutic platform that exploits pre-existing humoral immunity. The third experimental chapter describes a novel exogenous antigen-mediated immunotherapy based on the hemagglutinin (H) protein of the measles virus. H protein is a highly immunogenic antigen in humans due to widespread vaccination against measles virus. LNPs encoding H protein were formulated and shown to efficiently transfect both two-dimensional cancer cell cultures and three-dimensional tumor spheroids. Moreover, in vivo administration of H-expressing LNPs in measles-vaccinated mice bearing B16-BL6 melanoma tumors resulted in significant tumor growth delay. This therapeutic effect is associated with robust intratumoral infiltration of CD8+ cytotoxic T lymphocytes, a shift in the CD8/CD4 T cell ratio, and ex vivo production of pro-inflammatory cytokines upon antigen recall, hallmarks of a potent CD8+ T cell-mediated immune response. Together, these results highlight the potential of LNP H as a novel strategy to enhance tumor immunogenicity and elicit strong antitumor immune responses. We hope that the results obtained in this doctoral thesis will demonstrate the versatility of LNP-based platforms and support the development of innovative cancer immunotherapies that leverage alternative immunotherapeutic strategies, such as macrophage-based approaches and exogenous antigen-mediated immunotherapy., [CA] Esta tesi doctoral, titulada «Remodelació del microambient immunitari tumoral amb nanopartícules lipídiques», explora el desenvolupament de noves estratègies immunoterapèutiques contra el càncer, tant a nivell terapèutic com de mètodes d'administració. En concret, el treball investiga enfocaments alternatius i relativament poc explorats, com les immunoteràpies basades en macròfags i la immunoteràpia mediada per antígens exògens, que tracten de superar les principals limitacions de les modalitats immunoterapèutiques actuals. Paral·lelament, la tesi avalua les nanopartícules lipídiques (LNP) com a sistemes d'administració de gens no virals per a la immunoteràpia. El primer capítol experimental descriu el desenvolupament d'una nova plataforma LNP per a la immunoteràpia basada en macròfags. Les LNP carregades amb ADN plasmídic o ARNm de luciferasa es van funcionalitzar amb àcid fòlic (FA) per a dirigir-se a les cèl·lules canceroses pancreàtiques que expressen el receptor de folat i amb un anticòs anti-CD47 (aCD47) per a bloquejar l'evasió immunitària mediada per CD47. Els resultats demostren una transfecció eficaç de les cèl·lules de càncer de pàncrees, amb les LNP carregades amb ARNm superant a les formulacions basades en plasmidis. A més, la funcionalització amb FA va millorar la captació dirigida de LNP in vitro i la funcionalització amb aCD47 va restaurar la fagocitosi de les cèl·lules tumorals pels macròfags in vitro. Els experiments in vivo en models de xenotrasplantament Capan-2 de ratolí amb LNP-ARNm-FA-aCD47 van demostrar l'expressió in vivo de luciferasa i van promoure un canvi cap a un fenotip de macròfags proinflamatori M1 dins del microambient tumoral. En conjunt, aquests resultats presenten una plataforma LNP optimitzada, capaç de immunomodular els macròfags associats a tumors. El segon capítol experimental presenta una nova immunoteràpia mediada per antígens exògens basada en el epítop alpha-Gal (galactosa-¿-1,3-galactosa). El epítop alpha-Gal és altament immunogènic en humans i provoca fortes respostes a causa d'anticossos preexistents. Es van desenvolupar LNP que codifiquen el ARNm de la ¿-1,3-galactosiltransferasa (¿-GT) per a permetre la biosíntesi endògena de ¿-Gal en la superfície de les cèl·lules tumorals. El tractament amb estes LNP va induir amb èxit l'expressió de ¿-Gal en línies cel·lulars canceroses murines i humanes i va promoure el reclutament d'anticossos anti-¿-Gal humans naturals cap a les cèl·lules tumorals. Estos resultats identifiquen a la LNP alpha com una plataforma immunoterapèutica prometedora que aprofita la immunitat humoral preexistent. El tercer capítol experimental descriu una nova immunoteràpia mediada per antígens exògens basada en la proteïna hemaglutinina (H) del virus de la xarampió. La proteïna H és un antigen altament immunogènic en humans a causa de la vacunació generalitzada contra el virus de la pallola. Es van formular LNP que codifiquen la proteïna H i es va demostrar que transfecten eficaçment tant cultius cel·lulars cancerosos bidimensionals com esferoides tumorals tridimensionals. A més, l'administració in vivo de LNP H en ratolins vacunats contra la pallola amb tumors de melanoma B16-BL6 va donar lloc a una disminució significativa del creixement tumoral. Aquest efecte terapèutic està associat amb una forta infiltració intratumoral de limfòcits T citotòxics CD8+, un canvi en la proporció de cèl·lules T CD8/CD4 i la producció ex vivo de citocines proinflamatòries després de la reactivació de l'antigen, característiques distintives d'una potent resposta immunitària mediada per cèl·lules T CD8+. En conjunt, aquests resultats posen en relleu el potencial de LNP H com a nova estratègia per millorar la immunogenicitat tumoral i provocar fortes respostes immunitàries antitumorals. Esperem que els resultats obtinguts en aquesta tesi doctoral demostren la versatilitat de les plataformes basades en LNP i recolzen el desenvolupament d'immunoteràpies innovadores contra el càncer., This research was supported by European Union’s Horizon 2020 research and innovation programme under grant agreement No 899708 (ULISES). The work has also received funding from projects PID2020-119692RB-C22, PID2023-146637OB-C22, PID2021-128141OBC22, PID2021-126304OB-C41 and PID2024-155683OB-C41 funded by MCIN-Ministerio de Ciencia e Innovación and by the European Regional Development Fund—A way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012) and (RD21/0017/0012) Instituto de Salud Carlos III, the Generalitat de Catalunya (SGR21/01169). The research leading to these results has also received funding from “la Caixa” Foundation under agreement LCF/PR/SP23/52950009. The Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. J.M-L. is grateful to the Spanish MECD for his FPU grant (FPU19/06219). PM.S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). We also acknowledge the support of CERCA Programme/Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Smart Nanoparticles for Enhanced Melanoma Therapy: From Controlled Drug Release to Self-Propelled Nanomotors

  • Esteve-Moreno, Juan José|||0000-0002-1259-7663
[ES] La presente tesis doctoral, titulada "Nanopartículas inteligentes para una terapia mejorada contra el melanoma: desde la liberación controlada de fármacos a los nanomotores autopropulsados", se centra en el desarrollo de estrategias terapéuticas innovadoras frente al melanoma mediante nanopartículas inteligentes. En concreto, aborda la síntesis, caracterización y evaluación de nanodispositivos para la liberación controlada de fármacos. Estos sistemas buscan superar barreras características del melanoma, como la evasión inmunitaria, la matriz extracelular tumoral y la degradación prematura de los fármacos, reduciendo los efectos adversos sobre tejidos sanos. El primer capítulo presenta una introducción al cáncer y, especialmente, al melanoma, describiendo sus principales características biológicas, mecanismos de metástasis y evasión inmune. Asimismo, revisa la evolución de las estrategias terapéuticas y las limitaciones que condicionan su eficacia. Posteriormente, se introduce la nanotecnología aplicada a la medicina y sus principales aplicaciones oncológicas. Finalmente, se analizan los sistemas de liberación controlada de fármacos, las profármacos y los estímulos capaces de desencadenar su activación, con especial atención a las nanoestrellas de oro y a las nanopartículas mesoporosas de sílice como plataformas prometedoras para el tratamiento del melanoma. El capítulo segundo se exponen los objetivos de la tesis. El tercer capítulo describe una plataforma nanoterapéutica bioortogonal basada en nanoestrellas de oro para la fotoactivación controlada de profármacos de doxorrubicina mediante luz infrarroja cercana (NIR). Se desarrollaron dos estrategias complementarias: una prodroga de doxorrubicina inactivada mediante grupos 2-nitrobencilo y la misma molécula anclada covalentemente a la superficie de las nanoestrellas. La irradiación NIR induce la liberación controlada de la doxorrubicina activa. Ambas formulaciones mostraron elevada estabilidad en condiciones fisiológicas y activación exclusivamente tras irradiación. Además, se demostró la activación intracelular del profármaco en células de melanoma y cáncer de cuello uterino minimizando los efectos fototérmicos. Los estudios in vitro e in vivo en modelos murinos de melanoma evidenciaron una liberación eficiente del fármaco, una inhibición significativa del crecimiento tumoral y una actividad terapéutica selectiva únicamente bajo irradiación NIR. El cuarto capítulo se centra en el desarrollo de nanomotores autopropulsados para mejorar la distribución de fármacos en regiones profundas del tumor. El sistema se basa en nanopartículas Janus de platino funcionalizadas con lactato oxidasa y cargadas con doxorrubicina. Estas aprovechan el lactato del microambiente tumoral como combustible endógeno, proporcionando propulsión autónoma y depleción metabólica. Los nanomotores mostraron movimiento autónomo y liberación específica del fármaco en condiciones fisiológicas. En células de melanoma produjeron una marcada reducción de la viabilidad celular a bajas concentraciones, mientras que en esferoides tumorales alcanzaron una penetración intratumoral superior a la de sistemas pasivos. Los estudios in vivo demostraron una reducción significativa del tamaño tumoral y un aumento de la infiltración de linfocitos CD8+, sugiriendo una disminución de la evasión inmunitaria asociada al metabolismo del lactato. Finalmente, los capítulos quinto y sexto recogen la discusión general, las perspectivas futuras y las conclusiones. En conjunto, los resultados demuestran la versatilidad de las nanoestrellas plasmónicas y de los nanomotores impulsados por metabolitos como plataformas para terapias antitumorales innovadoras. Estas estrategias combinan activación controlada de profármacos, propulsión autónoma y remodelación del microambiente tumoral para mejorar la administración de fármacos frente al melanoma y otros tumores accesibles., [EN] The present doctoral thesis, entitled "Smart nanoparticles for improved melanoma therapy: from controlled drug release to self-propelled nanomotors", focuses on the development of innovative therapeutic strategies against melanoma through the use of smart nanoparticles. Specifically, it addresses the synthesis, characterization, and evaluation of nanodevices for controlled drug release. These systems are designed to overcome key barriers associated with melanoma, such as immune evasion, the tumor extracellular matrix, and premature drug degradation, while reducing adverse effects on healthy tissues. The first chapter provides an introduction to cancer, and especially to melanoma, describing its main biological features, mechanisms of metastasis, and immune evasion. It also reviews the evolution of therapeutic strategies and the limitations that affect their efficacy. Subsequently, the application of nanotechnology in medicine and its main oncological applications are introduced. Finally, controlled drug delivery systems, prodrugs, and the stimuli capable of triggering their activation are analyzed, with special attention to gold nanostars and mesoporous silica nanoparticles as promising platforms for melanoma treatment. The second chapter presents the objectives of the thesis. The third chapter describes a bioorthogonal nanotherapeutic platform based on gold nanostars for the controlled photoactivation of doxorubicin prodrugs using near-infrared (NIR) light. Two complementary strategies were developed: a doxorubicin prodrug inactivated by 2-nitrobenzyl groups and the same molecule covalently anchored to the surface of the nanostars. NIR irradiation induces the controlled release of active doxorubicin. Both formulations showed high stability under physiological conditions and were activated only upon irradiation. In addition, intracellular activation of the prodrug was demonstrated in melanoma and cervical cancer cells, minimizing photothermal effects. In vitro and in vivo studies in murine melanoma models showed efficient drug release, significant inhibition of tumor growth, and selective therapeutic activity only under NIR irradiation. The fourth chapter focuses on the development of self-propelled nanomotors to improve drug distribution in deep tumor regions. The system is based on platinum Janus nanoparticles functionalized with lactate oxidase and loaded with doxorubicin. These nanoparticles exploit lactate from the tumor microenvironment as an endogenous fuel, providing autonomous propulsion and metabolic depletion. The nanomotors showed self-propulsion and specific drug release under physiological conditions. In melanoma cells, they produced a marked reduction in cell viability at low concentrations, while in tumor spheroids they achieved greater intratumoral penetration than passive systems. In vivo studies demonstrated a significant reduction in tumor size and an increase in CD8+ lymphocyte infiltration, suggesting a decrease in immune evasion associated with lactate metabolism. Finally, the fifth and sixth chapters present the general discussion, future perspectives, and conclusions. Overall, the results demonstrate the versatility of plasmonic nanostars and metabolite-driven nanomotors as platforms for innovative anticancer therapies. These strategies combine controlled prodrug activation, autonomous propulsion, and remodeling of the tumor microenvironment to improve drug delivery against melanoma and other accessible tumors., [CA] La present tesi doctoral, titulada "Nanopartícules intel·ligents per a una teràpia millorada contra el melanoma: des de l'alliberament controlat de fàrmacs fins als nanomotors autopropulsats", se centra en el desenvolupament d'estratègies terapèutiques innovadores contra el melanoma mitjançant l'ús de nanopartícules intel·ligents. En concret, aborda la síntesi, la caracterització i l'avaluació de nanodispositius per a l'alliberament controlat de fàrmacs. Aquests sistemes busquen superar barreres característiques del melanoma, com ara l'evasió immunitària, la matriu extracel·lular tumoral i la degradació prematura dels fàrmacs, reduint els efectes adversos sobre els teixits sans. El primer capítol presenta una introducció al càncer i, especialment, al melanoma, descrivint-ne les principals característiques biològiques, els mecanismes de metàstasi i l'evasió immune. Així mateix, revisa l'evolució de les estratègies terapèutiques i les limitacions que en condicionen l'eficàcia. Posteriorment, s'introdueix la nanotecnologia aplicada a la medicina i les seues principals aplicacions oncològiques. Finalment, s'analitzen els sistemes d'alliberament controlat de fàrmacs, els profàrmacs i els estímuls capaços de desencadenar-ne l'activació, amb una atenció especial a les nanoestrelles d'or i a les nanopartícules mesoporoses de sílice com a plataformes prometedores per al tractament del melanoma. El segon capítol exposa els objectius de la tesi. El tercer capítol descriu una plataforma nanoterapèutica bioortogonal basada en nanoestrelles d'or per a la fotoactivació controlada de profàrmacs de doxorubicina mitjançant llum infraroja pròxima (NIR). Es van desenvolupar dues estratègies complementàries: un profàrmac de doxorubicina inactivat mitjançant grups 2-nitrobenzil i la mateixa molècula ancorada covalentment a la superfície de les nanoestrelles. La irradiació NIR indueix l'alliberament controlat de la doxorubicina activa. Ambdues formulacions van mostrar una elevada estabilitat en condicions fisiològiques i una activació exclusivament després de la irradiació. A més, es va demostrar l'activació intracel·lular del profàrmac en cèl·lules de melanoma i de càncer de coll uterí, minimitzant els efectes fototèrmics. Els estudis in vitro i in vivo en models murins de melanoma van evidenciar un alliberament eficient del fàrmac, una inhibició significativa del creixement tumoral i una activitat terapèutica selectiva únicament sota irradiació NIR. El quart capítol se centra en el desenvolupament de nanomotors autopropulsats per a millorar la distribució de fàrmacs en regions profundes del tumor. El sistema es basa en nanopartícules Janus de platí funcionalitzades amb lactat oxidasa i carregades amb doxorubicina. Aquestes aprofiten el lactat del microambient tumoral com a combustible endogen, proporcionant propulsió autònoma i depleció metabòlica. Els nanomotors van mostrar moviment autònom i alliberament específic del fàrmac en condicions fisiològiques. En cèl·lules de melanoma van produir una reducció marcada de la viabilitat cel·lular a baixes concentracions, mentre que en esferoides tumorals van assolir una penetració intratumoral superior a la dels sistemes passius. Els estudis in vivo van demostrar una reducció significativa de la mida tumoral i un augment de la infiltració de limfòcits CD8+, la qual cosa suggereix una disminució de l'evasió immunitària associada al metabolisme del lactat. Finalment, els capítols cinqué i sisé recullen la discussió general, les perspectives futures i les conclusions. En conjunt, els resultats demostren la versatilitat de les nanoestrelles plasmòniques i dels nanomotors impulsats per metabolits com a plataformes per a teràpies antitumorals innovadores. Aquestes estratègies combinen activació controlada de profàrmacs, propulsió autònoma i remodelació del microambient tumoral per a millorar l'administració de fàrmacs davant del melanoma i altres tumors accessibles., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22 and PID2024-155683OB-C41, funded by MCIN/AEI/10.13039/501100011033 and by the European Regional Development Fund (ERDF) – A way of doing Europe; by the Generalitat Valenciana (Project PROMETEO CIPROM/2021/007); by Project MFA/2022/049 from the Advanced Materials programme, funded by the European Union NextGenerationEU (PRTR-C17.I1); and by the Generalitat Valenciana and the European Research Council (ERC) via Advanced Grant 101052997 (EDISON). This research was also supported by CIBER – Consorcio Centro de Investigación Biomédica en Red – (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. J.J.E.-M. thanks the AECC Scientific Foundation, and especially the AECC Council of Valencia, for their PhD grant (PRDVA21651ESTE). P.D. thanks the AECC Scientific Foundation for their postdoctoral grant (INVES246470DIEZ). O.F.S. acknowledges the support from the Provincial Council of Gipuzkoa under the Fellows Gipuzkoa programme. F.J.H. thanks MIU for his FPU grant (FPU20/06021). V.S.-A. thanks MIU for his FPI grant (PRE2022-103714). A.G-F. and P.D. thank the Instituto de Salud Carlos III and the European Social Fund for their "Miguel Servet" contracts (CP25/00067 and CP24/00043). The authors thank the UPV Electron Microscopy Service and the CIPF Confocal and Electron Microscopy Services for their technical support. The U26 NMR: Biomedical Applications II platform from NANBIOSIS (ICTS "NANBIOSIS", Research Infrastructures & Services of CIBER-BBN) is also gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Development of Functional Hybrid Materials for Advanced Antimicrobial Applications

  • Medaglia, Serena|||0000-0003-3537-9842
[ES] Las infecciones microbianas asociadas a biopelículas y el aumento de la resistencia a los antimicrobianos representan un desafío crítico, tanto en entornos clínicos como industriales. En este contexto, esta tesis doctoral, titulada "Desarrollo de materiales híbridos funcionales para aplicaciones antimicrobianas avanzadas", explora nuevas estrategias para la prevención y erradicación de biopelículas, mediante el uso de materiales funcionalizados con compuestos antimicrobianos naturales. El primer capítulo se centra en el desarrollo de superficies de acero inoxidable modificadas con un recubrimiento antimicrobiano basado en vainillina, anclado a una capa intermedia de sílice. Las pruebas realizadas sobre Staphylococcus epidermidis, uno de los principales patógenos responsables de infecciones nosocomiales, demostraron una reducción del 100% en la viabilidad bacteriana y una disminución del 75% en la formación de biopelículas, en comparación con superficies no tratadas. El segundo capítulo presenta un nuevo enfoque para la prevención de infecciones asociadas a implantes, ya que las infecciones postquirúrgicas en ortopedia siguen siendo un grave problema clínico. En este estudio, se funcionalizaron materiales regenerativos basados en fosfato de calcio (CaP) con vainillina (CaP-Vainillina), con el fin de combinar sus propiedades regenerativas, con una acción antimicrobiana prolongada. La letalidad promedio sobre S. epidermidis en biopelícula, cuando se trató con CaP-Vanillin, fue del 98,9% y superior al 99,9% en concentraciones de 50 mg/mL y 100 mg/mL, respectivamente, en comparación con el CaP. Los estudios in vivo en modelos animales confirmaron que el uso de estos biomateriales no interfiere con la osteointegración, lo que los convierte en candidatos prometedores para aplicaciones clínicas. En el tercer capítulo, se abordan las limitaciones asociadas a diversos compuestos naturales mediante la aplicación de la nanotecnología, utilizada como herramienta para mejorar la eficacia y funcionalidad de estos agentes naturales. Este capítulo presenta dos artículos de investigación, que describen el desarrollo de nanodispositivos avanzados. El primer artículo explora una tecnología prometedora para la industria alimentaria, donde la contaminación por biopelículas bacterianas representa un riesgo grave para la seguridad alimentaria y provoca importantes costes económicos. Se diseñó un sistema basado en nanopartículas de tipo Janus, formado por una combinación de nanopartículas de platino con sílice mesoporosa funcionalizada con vainillina. Estos nanosistemas muestran movimiento autónomo en presencia de peróxido de hidrógeno (H¿O¿) y, con ello, una alta capacidad para penetrar biopelículas de Staphylococcus aureus y eliminar eficazmente las células patógenas, abriendo nuevas vías para soluciones de desinfección industrial. El segundo artículo del tercer capítulo investiga una estrategia innovadora basada en la Terapia Fotodinámica Antimicrobiana (aPDT), que aprovecha la acción combinada de fotosensibilizadores y luz a longitudes de onda específicas para generar especies reactivas de oxígeno e inducir la muerte bacteriana. Se diseñó un sistema basado en nanopartículas de sílice mesoporosa cargadas con curcumina y funcionalizadas con polimixina B (actuando como puerta molecular). Los resultados mostraron una reducción significativa en la viabilidad bacteriana y hasta un 99% de inhibición en la formación de biopelículas. Así, esta tesis doctoral demuestra el potencial de las superficies funcionalizadas, los nanomateriales motorizados y la Terapia Fotodinámica como estrategias avanzadas y eficaces para combatir infecciones por biopelículas y la resistencia antimicrobiana. Las aplicaciones abarcan desde el ámbito biomédico hasta la seguridad alimentaria, proponiendo nuevas soluciones para el control de infecciones y la reducción del uso de antibióticos o biocidas., [CA] Les infeccions microbianes associades a biofilms i l'augment de la resistència als antimicrobians representen un desafiament crític tant en entorns clínics com industrials. En aquest context, aquesta tesi doctoral, titulada "Desenvolupament de materials híbrids funcionals per a aplicacions antimicrobianes avançades", explora noves estratègies per a la prevenció i eradicació de biofilms mitjançant l'ús de materials funcionalitzats amb compostos antimicrobians naturals. El primer capítol se centra en el desenvolupament de superfícies d'acer inoxidable modificades amb un recobriment antimicrobià a base de vainillina, ancorat a una capa intermèdia de sílice. Les proves realitzades sobre Staphylococcus epidermidis, un dels principals patògens responsables d'infeccions nosocomials, van demostrar una reducció del 100% en la viabilitat bacteriana i una disminució del 75% en la formació de biofilms en comparació amb superfícies no tractades. El segon capítol presenta un nou enfocament per a la prevenció d'infeccions associades a implants, ja que les infeccions postquirúrgiques en ortopèdia continuen sent un problema clínic greu. En aquest estudi, es van funcionalitzar materials regeneratius a base de fosfat de calci (CaP) amb vainillina (CaP-Vanillin), amb l'objectiu de combinar les seues propietats regeneratives amb una acció antimicrobiana prolongada. La letalitat mitjana sobre S. epidermidis en biofilm, quan es tractava amb CaP-Vainillina, fou del 98,9% i superior al 99,9% a concentracions de 50 mg/mL i 100 mg/mL, respectivament, en comparació amb el CaP. Els estudis in vivo en models animals van confirmar que l'ús d'aquests biomaterials no interfereix amb l'osteointegració, la qual cosa els converteix en candidats prometedors per a aplicacions clíniques. Al tercer capítol, s'aborden les limitacions associades a diversos compostos naturals mitjançant l'aplicació de la nanotecnologia, utilitzada com a eina per a millorar l'eficàcia i funcionalitat d'aquests agents naturals. Aquest capítol presenta dos articles d'investigació que descriuen el desenvolupament de nanodispositius avançats. El primer article explora una tecnologia prometedora per a la indústria alimentària, on la contaminació per biofilms bacterians representa un risc greu per a la seguretat alimentària i provoca importants costos econòmics. Es va dissenyar un sistema basat en nanopartícules de tipus Janus, compost per una combinació de nanopartícules de platí amb sílice mesoporosa funcionalitzada amb vainillina. Aquests nanosistemes mostren moviment autònom en presència de peròxid d'hidrogen (H¿O¿) i, amb això, una gran capacitat per a penetrar biofilms de Staphylococcus aureus i eliminar eficaçment les cèl·lules patògenes, obrint noves vies per a solucions de desinfecció industrial. El segon article del tercer capítol investiga una estratègia innovadora basada en la Teràpia Fotodinàmica Antimicrobiana (aPDT), que aprofita l'acció combinada de fotosensibilitzadors i llum a longituds d'ona específiques per a generar espècies reactives d'oxigen i induir la mort bacteriana. Es va dissenyar un sistema basat en nanopartícules de sílice mesoporosa carregades amb curcumina i funcionalitzades amb polimixina B (actuant com a porta molecular). Els resultats van mostrar una reducció significativa en la viabilitat bacteriana i fins a un 99% d'inhibició en la formació de biofilms. Així, aquesta tesi doctoral demostra el potencial de les superfícies funcionalitzades, els nanomaterials motoritzats i la Teràpia Fotodinàmica com a estratègies avançades i eficaces per a combatre infeccions per biofilms i la resistència antimicrobiana. Les aplicacions abasten des del sector biomèdic fins a la seguretat alimentària, proposant noves solucions per al control d'infeccions i la reducció de l'ús d'antibiòtics o biocides., [EN] Microbial biofilm infections and increasing antimicrobial resistance represent a critical challenge in both clinical and industrial settings. In this context, this doctoral thesis, entitled "Development of Functional Hybrid Materials for Advanced Antimicrobial Applications", explores new strategies for biofilm prevention and eradication through the use of functionalized materials with natural antimicrobial compounds. The first chapter focuses on the development of stainless steel surfaces modified with an antimicrobial coating based on vanillin, anchored to an intermediate silica layer. The tests performed on Staphylococcus epidermidis, one of the main pathogens responsible for nosocomial infections, showed a 100% reduction in bacterial viability and a 75% decrease in biofilm formation, compared to untreated surfaces. The second chapter presents a new approach for preventing infections associated with implants, as post-surgical infections in orthopedics remain a serious clinical problem. In this study, regenerative materials based on calcium phosphate (CaP) were functionalized with vanillin (CaP-Vanillin) in order to combine their regenerative properties with prolonged antimicrobial action. The average lethality on S. epidermidis in biofilm, when treated with CaP-Vanillin, was 98.9% and over 99.9% at concentrations of 50 mg/mL and 100 mg/mL, respectively, compared to CaP. In vivo studies in animal models confirmed that the use of these biomaterials does not interfere with osteointegration, making them promising candidates for clinical applications. In the third chapter, the limitations associated with various natural compounds are addressed through the application of nanotechnology, used as a tool to enhance the efficacy and functionality of these natural agents. Two research articles are presented in this chapter, describing the development of advanced nanodevices. The first article explores a promising technology for the food industry, where bacterial biofilm contamination poses a serious risk to food safety and results in significant economic costs. A system based on Janus nanoparticles was designed, consisting of a combination of platinum nanoparticles with vanillin-functionalized mesoporous silica. These nanosystems exhibit autonomous movement in the presence of hydrogen peroxide (H¿O¿) and, with that, show a high capacity to penetrate Staphylococcus aureus biofilms and effectively eliminate pathogenic cells, paving the way for new industrial disinfection solutions. The second article of the third chapter investigates an innovative strategy based on Antimicrobial Photodynamic Therapy (aPDT), which exploits the combined action of photosensitizers and light at specific wavelengths to generate reactive oxygen species and induce bacterial death. A system based on mesoporous silica nanoparticles loaded with curcumin and functionalized with polymyxin B (acting as a molecular gate) was designed. The results showed a significant reduction in bacterial viability and up to 99% inhibition in biofilm formation. Thus, this doctoral thesis demonstrates the potential of functionalized surfaces, motorized nanomaterials, and Photodynamic Therapy as advanced and effective strategies to combat biofilm infections and antimicrobial resistance. The applications range from biomedical sectors to food safety, suggesting new approaches for infection control and the reduction of antibiotic or biocide use., The Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22 and TED2021-132114B-I00, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación) and the Generalitat Valenciana (CIPROM/2021/007) funded this research. This work was also supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032), supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolía fellowship (GRISOLIAP/2018/149). Á.M.-A. thanks the Universitat Politècnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). F.J.H thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021). M.R.-T. thanks MIU for his FPU grant (FPU21/03142). A.B. thanks the MIU for her Beatriz Galindo contract (BG20/00020). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support “Sara Borrell” (CD20/00120) and “Miguel Servet” (CP24/00043).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Metabolomic study for the identification of symptomatic carotid plaque biomarkers

  • Botello-Marabotto, Marina Dolores
  • Plana Andani, Emma
  • Medina, Pilar
  • Miralles, Manuel
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Carotid artery stenosis is mainly produced due to the progressive accumulation of atherosclerotic plaque in the vascular wall. The atherosclerotic plaque is characterized by the accumulation of lipids, low density proteins, expression of chemokines and adhesion molecules, and migration of monocytes and lymphocytes into the plaque. Its rupture can produce stroke, but embolic propensity depends principally on the composition and vulnerability of plaque rather than the severity of stenosis. It is important, then, to ascertain which patients with carotid artery stenosis have a greater risk of developing neurological symptomatology. Here, we present a metabolomic study by using nuclear magnetic resonance (NMR) spectroscopy in atheroma plaque and serum samples from patients with recently symptomatic and asymptomatic carotid stenosis to search for metabolites that could be used as biomarkers associated with plaque vulnerability and subsequent risk of rupture. Thirty-eight atheromatous plaque samples (24 asymptomatic patients and 14 symptomatic) and 70 serum samples (43 asymptomatic and 27 symptomatic) were studied by NMR spectroscopy. The data were analysed using multivariate statistics (PLS-DA) to determine a model to discriminate between symptomatic and asymptomatic samples (atheroma plaques and sera). The calculated PLS-DA models showed a 100 % sensitivity and a 96.6 % specificity for the cross validation to discriminate between symptomatic and asymptomatic plaques, and 88.37% sensitivity and 77.78 % specificity when serum samples were analysed. According to the results of our multivariate and univariate analysis, the most discriminative metabolites for plaque vulnerability were threonine in serum samples, and glutamate in plaque samples. Also, an analysis of the main metabolic pathways involved in plaque vulnerability revealed that D-glutamine and D-glutamate metabolism, and phenylalanine, tyrosine, and tryptophan biosynthesis were the most affected pathways in plaque and serum, respectively., M. Botello-Marabotto acknowledges Generalitat Valenciana and the Spanish Government for her PhD grants ACIF/2020 and FPU 2020, respectively. Andrea Bernardos acknowledges her "Beatriz Galindo" contract from the MCIN (BG20/00020). This project has received the following funding: Instituto de Salud Carlos III (ISCIII) (PI20/01171 and PI20/00075) co-funded by the European Union (ERDF, "A way to make Europe") , project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe and Generalitat Valenciana (project CIPROM/2021/007). La Fe Biobank (Hospital Universitario y Politecnico La Fe) is acknowledged for the storage and management of tissue samples (PT17/0015/0043). CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB07/01/2012), Ministerio de Ciencia e Innovacion and U26 NMR: Biomedical Applications II platform from Nanbiosis (Research Infrastructures & Services of CIBER-BBN) are also gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Cellular senescence promotes progenitor cell expansion during axolotl limb regeneration

  • Yu, Qinghao
  • Walters, Hannah E.
  • Pasquini, Giovanni
  • Singh, Sumeet Pal
  • Lachnit, Martina
  • Oliveira, Catarina R.
  • León-Periñán, Daniel
  • Petzold, Andreas
  • Kesavan, Preethi
  • Adrados, Cristina Subiran
  • Garteizgogeascoa, Ines
  • Knapp, Dunja
  • Wagner, Anne
  • Alfonso, María
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Axolotl limb regeneration is accompanied by the transient induction of cellular senescence within the blastema, the structure that nucleates regeneration. The precise role of this blastemal senescent cell (bSC) population, however, remains unknown. Here, through a combination of gain-and loss-of-function assays, we elucidate the functions and molecular features of cellular senescence in vivo. We demonstrate that cellular senescence plays a positive role during axolotl regeneration by creating a pro-proliferative niche that supports progenitor cell expansion and blastema outgrowth. Senescent cells impact their microenvironment via Wnt pathway modulation. Further, we identify a link between Wnt signaling and senescence induction and propose that bSC-derived Wnt signals facilitate the proliferation of neighboring cells in part by preventing their induction into senescence. This work defines the roles of cellular senescence in the regeneration of complex structures., We thank TUD-CMCB Flow Cytometry and Light Microscopy Facilities for cell sorting and imaging support; DRESDEN-concept genome center for RNA sequencing; MPI-CBG Computing Facility for image processing advice; Phillip Gates for technical support; Daniel Munoz Espin for nanoparticle advice; Gabriel Waksman for institutional support; Beate Gruhl, Anja Wagner, and Dominic Kruger for animal care; and all members of the Yun lab for advice and comments on the manuscript. This work was supported by an Alexander von Humboldt postdoctoral fellowship to H.E.W., a DAAD MSc scholarship (57507833) to D.L.-P., MISU-PROL funding from the FNRS (40005588) and Fondation Jaumotte-Demoulin funds to S.P.S., a CRTD E.V. scholarship to C.S.A., a DAAD Scholarship to K.E.T., CRTD-FSJ program funds to A.M.G., DFG (BU 2974/3-2 and EXC-2151-390873048) and Volkswagen Foundation Freigeist (A110720) grants to V.B., MCIU/AEI/FEDER, EU (PID2021-126304OB-C41 and PID2021-128141OB-C22) and Generatitat Valenciana (CIPROM/2021/007) grants to R.M.-M., and DFG (22137416, 450807335, and 497658823) grants and TUD and CRTD funds to M.H.Y.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Bioorthogonal Photoactivation of 2-Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars

  • Esteve-Moreno, Juan José|||0000-0002-1259-7663
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Ferreira Silvestre, Óscar
  • Gorbe, Mónica
  • Garrido, Eva
  • Renero-Lecuna, Carlos
  • Langer, Judith
  • Alfonso, María
  • Ibañez, J.
  • Roberto Cao Milán
  • Liz-Marzán, Luis M.
[EN] Bioorthogonal chemistry that can be controlled through near-infrared (NIR) light is a promising route to therapeutics. This study proposes a method to intracellularly photoactivate prodrugs using plasmonic gold nanostars (AuNSt) and NIR irradiation. Two strategies are followed. On one hand, doxorubicin (Dox) masked with a 2-nitrobenzyl carbamate (proDox1) is used as a photoactivatable prodrug. In the second strategy, a photolabile Dox prodrug (proDox2) obtained by modification of Dox with 2-nitrobenzyl diol bearing a disulfide is attached to the AuNSt surface. Under NIR irradiation AuNSt induce local electromagnetic field enhancement, leading to photocleavage of the 2-nitrobenzyl moiety in both proDox1 and proDox2, and subsequent Dox release. Near field enhancement by excitation of surface plasmons in AuNSt is sufficient to record the surface-enhanced Raman scattering (SERS) spectra of proDox1 and proDox2. The therapeutic potential of this bioorthogonal photoactivation strategy is confirmed in vitro and in vivo using a mouse model of human melanoma. NIR-activated AuNSt induce in vivo the intracellular release of Dox and subsequent cancer cell death, thus reducing tumor growth at low irradiation power density to avoid undesired photothermal effects. These results demonstrate that AuNSt are suitable platforms for NIR light-triggered drug delivery in cancer therapy., This research was supported by project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. The work was also supported by Generalitat Valenciana (CIPROM/2021/007). This study was also supported by the ERC Advanced Grant Edison (101052997). This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. J. J. E-M. thanks the financial support from FC AECC and especially to the AECC Council of Valencia for the trust placed (PRDVA21651ESTE). O.F.S. acknowledges the support from the Provincial Council of Gipuzkoa under the program Fellows Gipuzkoa. The authors thank the UPV electron microscopy and CIPF confocal and electron microscopy services for technical support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Renal Clearable Probe for In Vivo Monoamine Oxidase (MAO) Detection

  • Domínguez-Rodríguez, Marcia|||0000-0002-0635-0699
  • Azorín-Soriano, David
  • García-Fleitas, Jessie
  • Soriano-Teruel, Paula
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Lerida-Viso, Araceli
  • Soler-Beatty, Jennifer
  • Rodrigo-Martínez, Paula
  • Pau Arroyo Máñez
  • Rojas-Vázquez, Sara
  • Fariñas, Isabel
  • Blandez, Juan F.
[EN] Hyperactivation of monoamine oxidase enzymes (MAO) is associated with uncontrolled production of neurotoxic compounds such as reactive oxygen species, whose accumulation is linked to neurodegenerative, chronic, and age-related diseases. Although chromo-fluorogenic probes for detecting and quantifying MAO activity have been reported, non-invasive methods for monitoring MAO overexpression in vivo remain elusive. Here, we report a renal-clearable fluorogenic probe based on the cyanine-7 fluorophore (Cy7-MAO) for in vivo detection of MAO overexpression through a simple measurement of the fluorescence in urine. The probe incorporates sulfonic acid moieties for renal clearance and a propylamino group as a MAO substrate. Upon administration, Cy7-MAO is hydrolysed at the site by MAO, releasing a highly emissive Cy7 fluorophore, which is excreted in urine and quantified by fluorescence. Cy7-MAO is validated in vitro using HepG2 liver human cells, which express elevated MAO levels. We further demonstrate the in vivo applicability of Cy7-MAO for MAO activity monitoring in aged mice, which show significantly higher urine fluorescence than young mice, consistent with an elevated MAO activity in older animals. These findings support Cy7-MAO as a tool for longitudinal assessment of MAO activity in vivo, providing a novel approach to study MAO-related pathologies., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2024-155683OB-C41, funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund A way of doing Europe, and CIPROM/2021/007, funded by Generalitat Valenciana (GVA), to R. M-M., and PID2020-117937GB-I00 to I.F. The authors acknowledge the financial support from the FEDER found of the European Union (IDIFEDER/2021/044). This research also wassupported by CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB06/01/2012 and CB06/05/0086), Instituto de Salud Carlos III, MCIN. This study was also supported by the project PAID06-24 funded by Universitat Politècnica de València. J. F. B. thanks the support from the la Caixa Foundation (ID 100010434) under the fellowship code LCF/BQ/PR24/12050022. D. A. -S. thanks his predoctoral fellowship CIACIF from GVA (CIACIF/2022/132). J. G. -F. thanks his predoctoral fellowship GRISOLIA from GVA (GRISOLIAP/2021/122) A.G-F. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support Miguel Servet (CP25/00067).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

2-Isopropyl-1,3-dimethylimidazolium as a versatile structure-directing agent in the synthesis of zeolites

  • Yu, HJ
  • Rojas, A
  • Gao, Zihao
  • Gómez-Hortigüela, L.
  • Li, JA
  • Paillaud, JL
  • Camblor, Miguel A.
  • Villaescusa Alonso, Luis Angel|||0000-0002-2720-3217
[EN] Organic structure directing agents with low specificity offer opportunities for zeolite discovery by tweaking other structure-directing factors., The authors thank the Spanish Research Agency, MCIN/AEI/10.13039/501100011033, and the European Union for funding (Projects PID2019-105479RB-I00, PID2019-107968RB-I00, and PID2021-128141OB-C22, FEDER and TED2021-131223B-I00, "NextGenerationEU"/PRTR). H. Y. is grateful to the China Scholarship Council (CSC) for a PhD fellowship. L. A. V. also thanks the Generalitat Valenciana (PROMETEO CIPROM/2021/007).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

2-Isopropyl-1,3-dimethylimidazolium as a versatile structure-directing agent in the synthesis of zeolites

  • Yu, Huajian
  • Rojas, Álex
  • Gao, Zihao Rei
  • Gómez-Hortigüela Sainz, Luis
  • Villaescusa, Luis A.
  • Li, Jian
  • Paillaud, Jean-Louis
  • Camblor, Miguel Ángel
[EN] An organic cation lacking specificity in its structure-directing action offers the possibility, through the screening of other structure-directing parameters, to synthesize a variety of zeolites. In this work we show that the organic structure-directing agent 2-isopropyl-1,3-dimethylimidazolium (2iPr13DMI) can produce up to seven different zeolite phases depending on water concentration, the presence of inorganic impurities, crystallization temperature and time, and germanium molar fraction. The obtained phases are very different in terms of pore system, connectivity of the zeolite structure and structural units. At the pure SiO2 side, ZSM-12 and SSZ-35 dominate, with ZSM-12 being favored by the presence of potassium impurities and by less concentrated conditions. The introduction of Ge at low levels favors SSZ-35 over ZSM-12 and as the Ge fraction increases it successively affords CSV, -CLO and two distinct UOS zeolites, HPM-11 and HPM-6. These two zeolites have the same topology but distinct chemical compositions and display powder X-ray diffraction patterns that are much different from each other and from that of as-synthesized IM-16 (UOS reference material). They also show different symmetry at 96 K. Rietveld refinements of the three as-made UOS materials mentioned are provided. HPM-6 and HPM-11 are produced in distinct, non-adjacent crystallization fields. The frequent cocrystallization of the chiral STW zeolite, however, did not afford its synthesis as a pure phase. Molecular mechanics simulations of the location of the organic cation and host–guest interactions fail to explain the observed trends, but also considering the intrinsic stability of the zeolites and the effect of germanium help to rationalize the results. The study is completed by DFT calculations of the NMR chemical shifts of 13C in UOS (helping to understand splittings in the spectrum) and 19F in CSV (supporting the location of fluoride inside the new [4452], which is an incomplete double 4-ring)., The authors thank the Spanish Research Agency, MCIN/AEI/10.13039/501100011033, and the European Union for funding (Projects PID2019-105479RB-I00, PID2019-107968RB-I00, and PID2021-128141OB-C22, FEDER and TED2021-131223B-I00, “NextGenerationEU”/PRTR). H. Y. is grateful to the China Scholarship Council (CSC) for a PhD fellowship. L. A. V. also thanks the Generalitat Valenciana (PROMETEO CIPROM/2021/007)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Direct hydrothermal synthesis of zeolites and beyond: Interchain expansion and topotactic condensation

  • Yu, Huajian
Tesis doctoral. (2025). Universidad Autónoma de Madrid. Programa de Doctorado en Química Aplicada. Cuevas Rodríguez, Jaime Fernando; tutor., [EN] For conventional hydrothermal synthesis, organic structure-directing agents (OSDA, see below), type and amount of T atoms (i.e., atoms participate as tetrahedra in the zeolite framework), HF contents, water contents, crystallization temperature and time have been investigated in silicates, germanosilicates, aluminosilicates and aluminophosphates syntheses. We have discovered and characterized zeolites HPM-9 (stable low Ge UWY-like structure) and HPM-18 (new structure) by direct synthesis. We also obtained three zeolite precursors (HPM-3, HPM-22 and HPM-23) that give rise to three zeolites (JSN, MTF and HEU, respectively) by topotactic condensation. We studied systematically the calcination parameters after the hydrothermal synthesis, including various temperatures and durations under two types of calcination (in air and N2), as well as a combination of ozone treatment followed by N2 calcination for HPM-3 topotactic condensation. These approaches were applied not only for detemplation but also to promote topotactic condensation. By Interchain expansion, we synthesized two interrupted zeolites ZEO-4A and ZEO-4B using two different silane reagents to silylate and connect ZEO-2 chain precursors and obtained fullyconnected 3D extra-large pore zeolite ZEO-5 (HZF) by topotactic condensation of ZEO-4A and ZEO-4B., [ES] Para la síntesis hidrotérmica convencional, se han investigado los agentes orgánicos directores de estructura (OSDA, véase más adelante), el tipo y la cantidad de átomos T (es decir, átomos que participan como tetraedros en la estructura de la zeolita), el contenido de HF, el contenido de agua, la temperatura y el tiempo de cristalización en síntesis de silicatos, germanosilicatos, aluminosilicatos y aluminofosfatos. Hemos descubierto y caracterizado las zeolitas HPM-9 (estructura estable de bajo contenido en Ge isomórfica a UWY) y HPM-18 (estructura nueva), obtenidas mediante síntesis directa. También hemos obtenido tres precursores de zeolita (HPM-3, HPM-22 y HPM-23) que dan lugar a tres zeolitas (JSN, MTF y HEU, respectivamente) mediante condensación topotáctica. Estudiamos sistematicamente los parametros de calcinacion despues de la sintesis hidrotermal, incluyendo varias temperaturas y duraciones en dos tipos de calcinación (en aire y N2), así como una combinación de tratamiento con ozono seguido de calcinación con N2 para la condensación topotáctica de HPM-3. Estos enfoques se aplicaron no solo para la destemplación, sino también para promover la condensación topotáctica. Para la expansión entre cadenas, sintetizamos dos zeolitas interrumpidas, ZEO-4A y ZEO-4B, utilizando dos reactivos de silano diferentes sobre el silicato en cadena ZEO-2, y obtuvimos la zeolita ZEO-5 (HZF), de poros extragrandes en 3D y totalmente conectada en 3D, mediante condensación topotáctica de ZEO-4A y ZEO-4B., China Scolarship Council y agencia MCIN/AEI/10.13039/501100011033 (PID2022-137889OB-I00, TED2021-131223B-I00, RYC2022-036070-I, PID2019-105479RB-I00, PID2019-107968RB-I00, PID2021-128141OB-C22) Generalitat Valenciana (PROMETEO CIPROM/2021/007)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Recent Synthesis Routes to Previously Inaccessible Zeolite Porosity: From Ultrasmall Pore to Ultraporous Materials

  • Shin, Jiho
  • Yu, Huajian
  • Jo, Donghui
  • Gao, Zihao Rei
  • Villaescusa, Luis A
  • Hong, Suk Bong
  • Camblor, Miguel Ángel
Published as part of ACS Applied Materials & Interfaces special issue “Harnessing the Power of Porosity: Future Trends and Applications”., The diverse porosity and properties of zeolites, together with their stability, drive applications from catalysis to adsorption. Conventional hydrothermal synthesis has yielded a large number of zeolite framework types, the vast majority of which are synthetic. However, this approach still has limitations, as exemplified by the large disparity between known and hypothetical but feasible framework types. This Perspective highlights recent unconventional synthesis routes that expand the range of attainable structures and porosities: ultrasmall open pores by zeolite reconstruction; unfeasible zeolites with tunable pores by assembly disassembly organization-reassembly; the embedded isoreticular RHO zeolite family synthesized using mixed inorganic cations; shape selective small and medium pore zeolites synthesized via an excess fluoride approach; and phosphonium-enabled ultraporous zeolites (<13.2 tetrahedral atoms/1000 Å3). Their associated applications include selective dehydration, CO2 capture, catalysis, and decontamination. Although challenges such as scalability, organic structure-directing agent cost and emissions persist, these unconventional chemistries offer important opportunities for further evolution of zeolite structures for environmental, energy and health-related applications., We acknowledge financial support from the Spanish Ministry of Science Innovation (PID2022-137889OB-I00, PID2021-128141OB-C22 and PID2024-162542OB-I00 MCIN/AEI/10.13039/501100011033), the Consejería de Educación, Ciencia y Universidades, Comunidad de Madrid (SYG-2024-ECO-737, HALZEOCAT-CM), EcoPro HN, Shanxi Research Institute of Huairou Laboratory, and from the Korea Research Institute of Chemical Technology (KK2611-10 and KK2611-20). We also acknowledge the Severo Ochoa Centres of Excellence program through Grant CEX2024-001445 S., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Toxicological Profiling and Long-Term Effects of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles

  • Barguilla, Irene|||0000-0003-1081-4457
  • Candela-Noguera, Vicente|||0000-0001-5310-8443
  • Oliver, Patrick
  • Annangi, Balasubramanyam|||0000-0002-1479-138X
  • Díez, Paula
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos, Ricard|||0000-0001-7891-357X
  • Hernández, Alba|||0000-0001-6938-1233
  • Marcos Martínez, Maria Dolores|||0000-0001-7079-8589
Mesoporous silica nanoparticles (MSNs) are amongst the most used nanoparticles in biomedicine. However, the potentially toxic effects of MSNs have not yet been fully evaluated, being a controversial matter in research. In this study, bare MSNs, PEGylated MSNs (MSNs-PEG), and galacto-oligosaccharide-functionalized MSNs (MSNs-GAL) are synthesized and characterized to assess their genotoxicity and transforming ability on human lung epithelial BEAS-2B cells in short- (48 h) and long-term (8 weeks) exposure scenarios. Initial short-term treatments show a dose-dependent increase in genotoxicity for MSNs-PEG-treated cells but not oxidative DNA damage for MSNs, MSNs-PEG, or for MSNs-GAL. In addition, after 8 weeks of continuous exposure, neither induced genotoxic nor oxidative DNA is observed. Nevertheless, long-term treatment with MSNs-PEG and MSNs-GAL, but not bare MSNs, induces cell transformation features, as evidenced by the cell's enhanced ability to grow independently of anchorage, to migrate, and to invade. Further, the secretome from cells treated with MSNs and MSNs-GAL, but not MSNs-PEG, shows certain tumor-promoting abilities, increasing the number and size of HeLa cell colonies formed in the indirect soft-agar assay. These results show that MSNs, specifically the functionalized ones, provoke some measurable adverse effects linked to tumorigenesis. These effects are in the order of other nanomaterials, such as carbon nanotubes or cerium dioxide nanoparticles, but they are lower than those provoked by some approved drugs, such as doxorubicin or dexamethasone.